var title_f18_46_19168="Bleeding tumor a";
var content_f18_46_19168=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69084&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69084&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angiogram of the left cervicovaginal artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 494px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHuAUsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6bcHmq2WyeKilncvgGnI7d+9dSi1uecyWLOeasAfLg1CrfN0qyMYqJMcUVnXBqNsgdasTEDGTUfBqk9NRPcarUNkqaaAd3tU8acCh6BuU0jJYk9KlJIHFSSjB46VCe9NO4mDMeKaXI9aDQRkYqkApk4pjuc9aD1xQcAcU0gE3tg5qN3JpCeTUb0mBTu13E1kXMPyk81tydcGsrUFOw0miHc566G3PNZ0jnOAav3fJPrWVMdpNSSxJCCetRuSoODxTWIODmkcA9KQiN3A5PJpwc7c0wpQckUBcmjlYN1NSGYgZNVl+Xk0jv+VAFtZSO9Ryye9VJJsEVDLISRSC5DenliaxbnBbH860bs5yc1lTfOwwCKDOTIicd+lWEmwoHpVZgQAOtIzYXtyKLE3aLchDr05rNusg8VYD8c0ydd+MdaETJ3RjySgZLHGOevWiNy6kDBHT8Kdc2o6EcZzTUQqNqfWrsrHJ76lqSxuwyF796mLHg461Cp2AZyWB5xSF3252j86VkzRTtpcW5Y7Sc4x7VQlc7MZIxz61O8xIPbJH4VnzSFpM/gB61aRz1al2QXEh3HP6VTJBJ61K5JOT15qszNk4ANTKxnBt7s+4sZY4HOatxrkCqyAgmrMZ7U2fQ9SXhSKdvG2omOSKXBwKzt3HcguydoI9ahjuNrAGrrxb196iFoAcmqTWwmtSxEFdQ2KlxgVXQFBjtTzLg4xUNXKTsJN1FVZTjmppHz2xUEgJHWtIokRWyKSTg1GuQ3vUoVnHWq2AhZueKCxxipxbHI3MKVrf5SQcik2gsU2amk5p0y7ah3YoAZIeTVK6AKEGrcp+aq0wBBoJZy+oLhmwM1iXA5PFdDff6w1izryahkPcznBHUdKZnB4qwwBNQlcE96QmDMAucZpchlHamnkY9Ka+QKAJtny5qpIcEgnipEmx8rZ4qGdlPtQJkEj4b1qN5OeaRgSSahkzuoEEpDdaoyoM8HmppGxkVWkfjjn0FAmxrLuPT2qCWPb+FWA/rTJyMc/Wgh7FYsRgCnMcMPQUxxzx1NMduevSmZtjZcMpyPrVaSULkqOadK4GeQPX0qhNIAS2Rx/jVJdDCpOxYYqcnPfFNkkAQA8CqJlLRjb25yRSyuTCoyMDjrk1SiYOte9hjOCjEHOSCPXrVeR8DaVGAefepg25SvGB0JHvVSQ/Mx9+BTZhq9SB25qqWOfu596nlPWqx69D+FZVGbU0feTLyaRVwetSsBmhVzT5j6BrUcqZINSYwKOAKbuHeo1Y9iQUdaZuB70oPpSsO44qKhkXHeps0yTpmhMHYrEZphHaldjn0pAe9bIgAnNTqBGmehqFG+ccVNOcAClLV2GV5mLdDTElZG5pXI6io35FVbQRPKqyrkYzWXMu1sVcjkKtRdxh13rzSWgMzWPzYqtcn5DViQ7TVO7YKhNBJz2oN85I9ay5W4Oau38o3NzXO3d6AxAqGZtkssqq+O9NLhhWVPMHfcD0pVuMDqaQjTB5pruDVJJxt560jXAGaAuWdo9ahmXjPUiohchupHHSh5lYcEUBdEUjFQe1QM4OCTxUsh3ZOaol8uQTkUCbFnzmqcmQWOc1ZkyT6DvUTqF96CJEC53YNOnYEA46Uq5yM8c0kg+Yk0XJ6FViQaZIACO4PWpDjf2qGYEtzzTM2tCpc9Pl5FZsykMWHUHkZrUcEuxUn2qlPGu4EjqckDtWkXY468boq535zkDHJFO+4pzGOFxipViKg85GMdKgLEhxvwcfSqfkc9raMjkOFBCsGHfmq0jEknHWrFwSqFS2cnJ/xqo59xU3KerK7nrVYgk5z+tWJDyaqsx3HCmuaq9DeCPvxvvGnqOKafvUpbArQ91ivkLVdn+Y9jUjvnjNV5MhunFVFCZKG4qVTxUEYycVKOBQwRIpJPPSnEZWmIcilY4FQVcruOTTDgVK4zUDZBrVEjk+8MVNcD5QagXOQassN8Ix1FJ6O4IotTc1KwA4PWoHNV0AR+BlaIpcHa3Q1Hkk00jBzSAZewkHcvIPNYupkiAiuiRgylWrI1m3KQsR0piZwWqzCNG/GuNnlLOSz9K6zV0I3jua4q7BSXGPqazOeRYjfjk1Ir1miQhu/AqcT8CkJSLbPiopJDvGc47VAJuTzxTi4Zcg0A3cl3nGM5NDOcVErgrmnBsnHUHpQBLFIXQ89KrMCXz6VNARkgdqfszzigN0Q+56mmsAD7U9wM0h6GgCELlqbKMdTUiZ3e9JOmQfpQiXsUlIQcngVFIVx254zUmzk1G6EdfzoMyscjGeTUEpwrOQM46elWhHnkdelRuqtuBz657VSMZx0MqVn2nOEGMjnrUMy4cEMTkd6tXILMSVUgDPXmqshJXgjGQPpWvmcEuxWfPIPWq78VYfvmq0h+apkOBBKfl4qAuueQc1LMeKg3egrlqvY6oLQ++5Wxk1Weck4ptzJyQKrhsnNdKVj2my0HORnpTyM8+lVVJ4qyrYGKYbksPXNSHrTV4TPrQXzxUbgSAhRSM3FM3GkJ4pJBcCajelJxTSc1aQCDOBU8L44PSoQwGKcDg0NXBBdJhsjoaqsBWjxImD1FU50IJpRfQGVH4NRs/FSyA1C+RxzTARXGKbcMs0LRSfdNMfIOagnJ2ZzQI5TXtOMTEgZTsa4XU7bBNerykTqY5RwR1rkdd0hopCQuUPQ1LXYykjzi4jKPg9DUYLYrevrIhiMVnta4Y8VJi466FeIbiKsCMYI71JHBs7ZqZUG7gcUDUepSaNl6U+NSTk/lV5oQQOKaYSDwKCuUhijJl/GrRT06YpPJIAPQ1NGmH5NA7FcxL3qJ15+UVqNGvUVXmTB4oBlERkEkdKjmU7c55FXOTng4qpcHIJxigloobTuyelNdNxHWrA+7z34qGVeVKnp0oIasiBkAA9ulU7klRtTjB61oP057VnXUYZznoKaZjUTtoZ9wQAQuWz1NV3wB82Mdjj8ulXpl2qpVcdzVOZhgBs5PpWqZwSjrcpSHqaqy8mrMxAzg8dqpytwRipkxU0V5Gzmod+Mjmny1WZ2DEDFcdV6ndTR93TOTI31pik96lngdWPBwTSRoEOWPI7V2o9RkkYIXLVKnzGoGkBNT2/UsaNhllj2FR52n05o3A0HBWlYBxbIpDnrSbSPcU9RnrQBETxSE8ZqVowR1o2GmmBDzmpohnqKAh3DpjHPrTguBxSbAlRTu4H1pLmPK5xToOtTsAVIrJuzLUbmSyDB4qB4u9X5U2sahYAg1smmQyhIgx1qtOnyVflAIqnMMA80CZmyxc1EcSKY5hlT3q7IeOlZtyWGcGkSzB1rSPLJeMAxn9K5qey2uT0ruY7k5KS8qaztS0zBMkfKHmpa6ktHJLZ4JJ6UptAeQK15LfaMdKgdSnGM1IrGesYUYPFNePFXJQGGB1quRzg8UCsQuML2pNowOeakdQBzUQbHFAC7v0qGQktx3qVeScmkZevpQIjQYVqoXIIPTGavk4jNZ1yxLfU0CbIQvbHSo5TtPIqXf0FVpz8xGcUGbI3YBTzVScfKfeppW29qz55gQ2KaVzGcrIhkcFjzn/CqE5KFjkjv+H+FTMFO/DckHkmqczFjkntWp58pXepWlPFVZOM1Yf6YqvIOOtZyZcEVHPWqjkbjzVmXvVQhiSQ36159Z3dmd1NH6Byy5yD0qrItSsMsfamycAAV6aVj0mioeD6VMk4SLGck1DPxgUzAwKLivYkeZiODTo5XOAah709GwaQXL8bEHrVhCGHvWercDmpI5CDRa4XNDFGKiSQHipCeKlooDSjoaaTnrTxjb9aQCRH5xVgHBFVhxUwOQKmSHF2EuEyuapNwDWgeRVSePafY1UH0CXcpSjINZ8ucmtCUY6VRmGCa0IZSl9KqyqpHSrsx4NUZDkZFIlmdcQgNkVJBNtARxlTUrrkc1AwqWwsRX1hlDJGMiueuYyCa6VLkwttblD2NVtTs1ljMkC5z1AofkJo5Zxg1GwBGe9WZYWVsEHimJFz0qSSq44Jqnty+T0Fb8VqNp3fhTJbRcZA4osFjI245HOajlbjFX5YdoqrLFxknpQJoiRcpz0qhdoM/L0FaAJC4B4rPuW+YjFBLKW3AJ9Kqy53d+atkkZ55qtM/IOMnNBm2ULk4JC/eFZ0zcMQMk8YrRujgk7eRzmsy5dVZi3UDggVpE4a2lypKxDnf16VVkOcDAAFTyD5sfNnAHPrVdhxnPfpVN3OVRsyJ+lVZD61akHFVJeD1rKRvT1KsxPaqDuQxHy/jmrs+T0qkzHca82vqzvpI/QWQgE+9VppgBT5XJYiqFxur1jvYyeXPPpTBMSBio2B2nNOtkJHORSJJQxNPjJyKUIMcGlQYOKBkqvU0XNQhOanjG000CJkyDU2/gVDTguWzRuMlQknmpe1NVQo680M4AqHqAmTmpkb5aqs3IxUsZyvNNrQC0pytMlUMppkLjJBNOnJC5FZ2syt0ZtzweaoysT3rSuV8xNy9RWU+SxFakMgmHtWfKOOK05EOMk1Ukiz15FAmjPcnNQyD0q68fPpUZiHek0IzJoywptvM0DYbJB9a0HjGcVWkhDMBjNIVrDbixS6TfEBn0qgtiUJDKRitezJgbHVfer80UdxHuTAamkgtc5ww7RVO4IUmtW6BjYgjFZNwu49OtTsJmbdtuJOPwqlIQU5q/MuMgdT1qlNFxzSE9iAfd9qz7wbWPtWkq4BOeMZrJu2yx7daCGU3bJqlK+CSD61PKSM8cVQldiRnGD1oWphKViGZiVJOcexrNupAzOFJA6gn/PsKsTzBQVPcZzkVQcZydwPOOeK1irHn1p3dkRt8xIHrjPrUTEcfQ0rMcYzwexqJjxQ2ZLUjlJAqlKSc9cVZlbrVVjzWM3ozppqxVmJqlICXOCMVbnYZNUnddxyOa82rK83Y9Ckj79mbLEn1qu5BHBokfMhGO9RF+a9c63uBHGDQvHFBPNMf2I/OgRPuAXmiJst171ULt05pYc7s5oC5rRjjOc1MB6VTiYgDmrceeO9Mok28Cl3EVHe3dvY2c1zeTxW9tCpeSWVwiIo5JJPAHvSK6yRq6MrIwBVlOQQehFFwsP83PQ1E0pyaawxzSYyM0XAeZDkYqeByeDVZcKKkiPcUAT7sN1q4MSRfhWWG+arsUm1RzgVMlfVAmRN8j9PrVa6iH31q1fdmHQiqYkLLg01tcCq3Q56VWkIB61cmjwNwHFUnxnpQJlaXr04qFuRU0ucdKhwS3tQSAQEZJGKrsgBJxVmQgL71BIeKTAibGKZFcGN+DTJSe1RKhJ570rhc0J0S8j+X72Kx57UruBHIq9GzRsMHpV1gk6YOA9NoVrnIzwhTkiqE4A49a39Rt2RmBHFYtyAoORUMTVjMnYLwKyLzGSfQVpXTjHFZkwJJ460EMz5DuU1m3WeeMDtWpJhRgYz9Kzb5QQewFNHLV2MeVDIu7Ay3A9+neqj8p0AIPpz0+tXXBGULAjbz6iqhyrc4O04xjpWp5stNisRzTJOvPepiNzEgbRmoZDjrSYIqynrjmq74qxL0qsx46Vzz10OqBTmHBHFU5N288E/RquynriqMmC5IB/CvOk7Sujvon3hdEhz7mqrErzVuf5pGz+FVZ1+XivZR0sTcTVeXcG6mhQ4bjNOIz94UhDVnI4HNWYJckE1U2AVPAMEUAa8W3GavRSDbWVC3arkL4GKCrnL/FfwNZfEHwu+l3crwXEbedazqTiOUAgEr/EDkgg9jxg14p8KPiHqfw611vAfxELQ2kTCO1u5CStvn7oLd4T2b+Hvgfd+lQ3Jya4L4vfDmw+IOheW+y31e3BNpd4+6f7jdyh/Tr7VMl1W5rCatyy2O9Zsrx0pucCvnr4JfEi58P6h/wAK/wDHatZXtm/2a0nmOMdliY+mMbG6EYHTFfQDMM88U0+YmceV2ZMoLVPCuDyaqJIOgNTxudvNMkWQ/PgdKsQ8jb61A23OSetOWeNGGTigC3NGWgI9KzhuQ5xzWskivGSCCMVlXF5EuRwaUewMWQEoHxweoqrcQAHI6GpY72ORNmQCKI7qNm2tyKoW5mSxHNR+XtUmtqSKM8jkGqssKnOKLA0Y7KxJzUbRkngVpvBjoDUMkWR6VLQjNdOoqMpWiYSc8HNRSoFB6ZoaFYoldp603cR8wqV++KrliOo4pA2OaVLhNkvX1rmtdi8o4A47VpX8nlglTj6VRNxHdIYpm+nrSJbOZkPJ3VTnIxj0rT1G0eCRiOV7EVj3IOOARmkZsozSY3FuorNuWzuJwcDpmr1xgZIHPSsu8JMRMZ6DJqoo5asrIoXDHeXAwCOaqsd5IXGW6gGrLbtqoeA2W6D3zVabAclfu+wrRs83zInJQlT171Xk96mdg3OBnH6561DJjFS9io7leXjPNVZGx1qeRs/hVR+prmqM64Igl7kVmSy4kYZ/lWhKTtJx09aoELk7mwc9Nua87eTPQoI+95Bl29jVZyS2DVo5MzDHNNEYLc9K9o2GCMbDxVd1wTWiy4Xiq0qjBoAqBec4p6n5hxRjGRRkBqBFpOKmD1S8w4qwjYQFjxQMnWTDYNSGQY64rPknCt8lRNOSOpzQO5wPxo+Hdl480zzofLt9dtlItrnHDr/zyk9V9D/CTkdSDx/wb+Jl7Dff8Ib43MkOrWreTbzznDPjpG57t6N/EPU8n2WRsnk815p8Xfh1D4xsvtun7bfXrZcwzA4EoHOxj/I9jUNW1RpCd1yS2PVku2B9KsC5kKEg9q8N+DXxFn1C5PhfxSGt9ftiY0aUbTNt6g/7Yx+PWvY0uI9zQ+YplVQzICNwByASPQ7T+R9KpSuRKLi7MvNI7gFm5pwUtjnNVY2LIfapI5CpznimTc39OI2lCc+1YmsxiOVhHgD0FaOjP5kshzwBWP4iyt7Jg9RkUu4PYo2+5pgMkVHczyLKSpI5qos7xybgxGKlursNCJCBk8UXFcs2+qTxtskbch7VeS9Y4/unvXNNdryemTTP7TaLo3FJMEztIpVdQSaR9o54zXK2urmXCkgMOhrSgunkGGzkVSY73Ls0u08VQmk3HrU7sSORVZyM0mIhJ+U4qjO5APIxV1zwQDWdePtGKkGZt3Lu3AnNYVwWWQlcg9a07k/MWHFZlyykc9aTM2S2t2HXyrjlT61Q1i02EvFyh9KY7dMCpobvadko3IfXtQLfc5q4UZOfvCsm+B42jrnOfSuu1SyUZlgO5SM1y98pDjg9eaqLOOvFpWMtlHmMVbkDkCq8mPnB5JPHPSr7J8uxVypOc96rNbSKGyvQbulaHA00Z7jmmyYwMVNIuCdoI9qheplsCZTkXg1UkHJ5q/KM9KpTjb3rmq2SbOqmzPmZtxGSFPbNVHlCNt4OO5FWJmJbHbOCars7IxXa3HFedG8nc9SloffTON7cUbx6VA3+sb1yaGNe0aMs7srntVaQg80pf5eDVdmJPNAmxWAzxxUbDkU4ZJoI28mgQquqLlu1QNOZCeeKilcsxHrUQXbmhsCfdk4NMZz2qJCS3WpVXJ54FIBVBK5J4puBnpmnSHjA6CnRrkZNCVwPnX9oPS9Yk8QW+r6X4XuLcWZBbVoGEjTbQCrFEJ2BSD8zcnjpjFU/2avEF1N411m3v55rmfULYTPNNIXd3jYAZJ5PDt37V9MSHCYxiue/4RLRv7eg1mPT4IdTiLEXEQ2M2VKkNjG7g984wMVm4a3N1VThyvsdHaOSSM5zT5W2DBFR2sZEgParN2nOcZrUwJtBkxM/JGRzVbxIf9KZzyMYq/4fh8y6dyMIqnNVfEKpcM5if5k420htaHLSyBmPPNRam+20i2A7O9JOQhJqtFdEF4pBmNh37VNyGykZ+cZ6CmNJmmXsZimI6jGR9KI4n+ztNjIGFpANE5icFW5FdBY67LNKDIFzx0AFcs+duSKmsiVlXbycigSep6EkwlgV+h6VC+PzqbTLUvbRMxyO4zWi9mvlHAHFXa5oYEg4PtWLeyYJzW1f4iUjmuavXOTngUmS2ULuUZOBzWXMc4Iq1dSAn61nyP8AN61LM2wXnJPGOtQyuO3XtUjH5eenWoFwSS1AmJDcyRqS/wAw44qrqNklwvnW2Cv8S1NMpIzkg9qZZmSOUEA4J5oWhDV9GYTwNFKPlwPSmy+ZJEyqu1+tdnPpcdzH5qABz2x1rMuLBYs547VXMYug1fscXLDtXDqw64IHWqVxAV6Htk8V1d15CHDAHaCR7ViXdxGhBTBPNVe5xypqnpcxJFdCQwIPfNZ18C2CMcda0LyfcSQMZrKnk6DHJH+fpXJiGrWNqKbdymdqkZBP41UuDI0zHjnnlf8AGrknQkY4qrJOgch1G7vk1w021oenSZ95MwMrexNKeRUJ/wBa31NKHPevZLFzg9aa70Agnmo3AzQIlUjHFRzNhaBwtRTMNpobAgZsHNQyP6UrMNx60zG41LAmi5FWuAmcc1WjGBxU+flx6UARHrU1uCeKiAyat2qYamgGToSwFIsWcY/Gr0seXGBzVi2ti2FC8+tOw0irDHjHHFW5IN6cLmrq2yQ4MtTyTxRpnaPai47GeA9pZOqcSOCSfSsSSPZp80mfmHGOprTvZg027nYaZbWaziQq3y4zg96AaOIvFbuCPr3rJmUjJzzXXeIIwGAQDj865S66moZm1YsWeoWaWx+3W5mmQ/uznH4GqNxe+fGyIqxpu+4OwqhcZVuO9Rwgs2ckYpCuSMrscZP51btcQHP5k1AzCPJJ49KqvKznqfpQI7XTtRbygqMQK3bK4YLuc8GuI0liUUVuG5KR4yRVJlpk+tiXzSYwGjPQ1y11IeQ3BrXku2YHBP4mszU03KJF5BHPtSYpGFOfmOOlUZic+oNWLhv3hwarE7mJ6e/rSM2wd9qhR+P1qMN5jKvQCoXch+PWtDTbQzkvjigS1HC283t8tSiGO3XLflVqdlgQovUVg3c7SnGTn60DbsXZ9TMBynArM1C/F9GWiO2QcAZqGcFhg9Ky7hxC4MJCnPWmkYVJtXMm6kkDkEtnv/n61mzE9DmuqlaG9hPO2QAcj0rA1CBoXIcYq27o4JRcXfdGHck4PBqhLuOa1ZuetVJVzniuDEU+Y6qUrGa38QY7cdyKzpNpc5YfmK07iMlSc8/rVNmYk4SP8QK5qaR6VGzPu5ziRvrSZyDUMr4lYY7mjIzjnmvYB7kgbimF8t700sO3Woy+GOOtFwLDONpGarStlaa0nFRF8jNJhcaeuSaAT26UvBpOFFJsCaM8CrKoSPaqkTZbrmrkZyPWmgFRBu6VpWUG/wDDpVJeKuWUu2TvTGWwiryR82amhLbgQQO1MdVbDZPPamSyrFF8mfWgrYnnbDEynJ7DNZ1xPuzk4qrPcMX5JzUTPvOc8nrQK5cUI6kNyaRnMTFVyoC5zTrKM+W0jA7AePeo9VmWaIqgwfagGcxdTHzWYnIz39KwL0BWyOlbF/xkVlTbWXb+ZqGZsyZMO/sKazCJc9KsXMYTlenaqEm5254pEsjmdmbPamrwRTmXrmkjjJcAeooBanR6OP3YPNWb2XaQM0yyj8mEDPSq94+8mmMqzXG3JzUQvjhlPI7iqlw3JFQgnOTwKQmxl2m58p3qhMrKcY61obwHOBTZjuUEDmgmxRgg3tuYcL1rSN4trFsThqrM4jQ8YxWdK7SyE5wOlAtti4JmmY9ST1pjwgHI5JqWCIxIM8t3qGVyM+tAW7lG+OxWzk4rBu5QRx0Jwa2NQmyOaxLkbmHfLc1cDhxL6IrOxQMyO24nnjrTJLqO4Hlzgg/wtn9D3pt4cOcDFZsxIb8KcmcsL7DLmIjOOR61Rk79qvrNkYaoLiENkpzXPVjzLQ6Kbs7SMqQYOO3tVORQXJBUD/PvVyUY9RVCZcSsM/lXmw3dz0qR923FuwkYnpmoJAEWrzTb3bPrVS6UYO0Zr2jZme8pB+tIXJ+ppk4OPSoVZt/tSYiQ5waiZmUdKsqAVye1QTrwR3oEMSY56U4OWNVn3Knyqc0KzYBIqRM07ccZrUtAuAHIAPesGCVgcCtGKTco+amikbltapJuy4z/AAgd6WNRHJjGe2cVn20hDAhjxV1p0woz83U1Q0aU5TCjhQBWZdyIEP0qaZ/Oiyp5ArFvpCvANDG2RzSgZOaht5SZQCTgmq00h71Wt7nZKM+tK5DZ1qag0CYUArjGDWTdXTOWkGM9Ki1afYYin3HXcPzrNlkxB83f3obG2OvQJ1LgYPWsG5lCdODWtBMu1o2OS3T2rnLsM0jexqWQyGW4LHafWoSTnNIVAbDt83bFIOZNn8XUikJsa5zU9lCfNU470+2spZmOxSQOp4q4q+U2MUAl1Lwf5MegrOuZMMat7sR5z1rMunGSfegbZTkPzEk80xnLe1RTSHPBxTIm3MB1zQR1LPkkuGzkGnTJsQqepq+sYjtlZ+CfWq1yuFBI4NBTRjXhwMEGmWKbpNxHA/nTrt9xbnip7RMQL2J5pGa+IfIxGfeqFzJt561auyRnbWRdOcg9fU00hTlZFa6lUj5setZV4wJCgct6d6mvHKkjlup6VnkqQ5bGQK1irHmVqjk7DLxhtIwQc/h0rNlPrmp5Dkmq755qZExICMH2prS7c/rSucKe1V5Tz1HNc05WOmMbhMqyDK8EVkTWq+a2WwfpV5pducE1F5jtyAOfYVxykpO/U7KKlHY+2J2IkfBHU1EkxJINPnQiV89yagZOc4xXq6nUyZow4qB4QpJPFSq5U4qTIegTKRFVpshjitSSHaOMVn3MbDdgc44pMRVDDGD1FS5Urg9agZNpy3Wg9ARSEC5D4WtC3OOeuKy1c78irSSkChMZqRS4GQetW42L47e9ZMchOBmtC1l+UVSYzSg+RWrLusFyepq+shDYI4NZ91uLsM9+1NhuZ10gJ44z1qhbxFrgYAKr83JrTktzyZWOMcCqAlW3WQE4Q9fU1LEWdQkJhSQ8/Ntz6ViXl2BHt3YNa8M4liltSfkcZ5rkr9sgg8MpwRSYm7FizuSLhSrcg0zVJf3xAwAe1ZcMrRyg9cVd1oqfLdDkEUkS3oZ8h3MTjpU0Milc/wAYH51SV8Ek0+KUfMB3/SgSZqafqP2dGjkQMpOc9watCTzm35znn6VzxzvGM1r2MhRc0DTutS67YjwTisq9fBP1q7M2U9ay5yW5PXNASZSmPzHAoszm5Qe9JJ0NQQsRMNvrQTfU6fVHyoAH0qK7BW1DHsM0+4QyKnQ8VNeREWP4UFM5OTLOfc4q+BtQCqzx4lX61YuORx0oIiVLksTnjFZ86qUO4gCr8wIUkGsy4PGCeRxihGczLvYwZQF5JHP0rMuVCBlHqO9acrGR3ZcgDpWVOy5yWyx/StUeZUSvcqkDueO9VpWGeKlZz3qvICWzUSZUF3IZCQD6Yqq/IJqxISeD9etV3HeuOq7nXAquW5ziqxPPIarMq/KRjtVNzhiB0rg66nbSPuuYZZvqajZFx6VJMQHbjnJqB3IxzXumrInGM00Z7HFSFlYVHnjikJjJZ3Xg8io3mVxilmw1QPF8px1FJsVyOdQelL9nDRAg5zUR3AdaeJiiAcYoQiF42Q9Krs7h+eRVuW4BXkYNZ8067xkmkwZp28hJUEcVr2oHG44rnYrkZGM8VfhvCMAdaaZS2OjdlMBB5IrLmlVSc0JcFkxnrVG5OM8073QNkVzfHkZ4FZN1Lu5NWZEDsTVKdc/KKl6ksktpCsTyBiGXpVG/iFxbNcx/fDfOP61JIcbVXnsaZYt5rzQlsbkJGfXrQIwZsKfenzyGS1XJ6Ul2vzH2quSxhK4OBSJ30KzyYfHFODFOQarvkH3oDZ4PQ0EXL8MyyH96MkccVbhmIHHNZcRwePrVuI55B60FJl9pSU4NUJGJJ/GpQ23jp61XmYqevBoBsglYqOeT9KhtzmdTwDTpHyhGeajt+ZRzigndnZWse6OPdycVavI82DYXBFM0pPMiRj1xya09qlHU9DTsbWucJcRkOC3HNLKnetDVrMxyMwyRniq6LviHH1pGa7GTPnB9M1lT48wgnjvit69j2qTnFczqUqxhic5yeaaV3YwqtRV2UNVn8tRGh6jmsSV+c9qmuZd7knr9KpStuNVJ2R5/xu4jHrUecnilHOcmkYYz71FzRIhkB7HioHBxk9qskgjjk1CwJBGDXPUj0NosozE8c4FUn27jknP0FaU6Bui4qm6gMa4Xe+p20pI+5JeXb6mq0iknNWJgRI31NRnkV7Vjdldhgc0wHPSrMiZFQkEcCkxWIWFQyk44qSTcPpUco+UmkxFKR2BOBUQnA69akkz6VVkjLZNIQ+SRWjNZtw5BIH4VLIrZ2g01sDgjmgCJZHAGTg1PBO+RzxmoHBLZxxT1IFIDYivMDBJp7yrIpweaxC5znNSJMw4zTTC5ekbBGOahlQODjg0yNi6nmlSXB9aAKijbMuRu5qrYAR6gmckb8GrVw+2RiDx2qlE2yR5W7dPqaQmVtUi8q9uFGNu87fpVUnERDDrWlrdu0EsXmD55YxIB6g1lTHjFDJehRmIyQD1qBhtGeD2p8xwTn1qJ2H4UGbZLHIA3B7Vdt3+X3rKQkseBj1q5buR260Diy+WyahuOV/wp4OcE0yY5Q44OaCtyjIOSM0+BMsvbHSh0JAJJyK0tCsnurlflyg5NImKvI7Hw5DmzTeMk1LegxP0708XCWUaRsOR6VJKftMXmgcdao3ZmTwpdRMrcHHFVI9OMKnjI9avviNuPxpxuVERDYwBQKy3OS1aLG4EY+lcFr8mJVXr1zXb+IdSRi4iwevNeb6hIWkJPTnHPvTitbnn4uatyoz5j1/SoCee9PkPPpUR60pO5zRQg68cc0v3h0/GlApw4PSpsU2R7cD3o2889KkOMVGx5IoshptlaZOSfWqhUA8gZ+taUmNhxWc5Jc4IH51yV6cbq500pXPuq4tgztjrmqT2pU8VtOMMTUMgyK9A9FmJIjAdKgbgmtl4wcjiq01vk9KBNGRIc8YxUcmNtXpbUgcVUlhcA96VhGfJjfz0qKRRg4qzKpAyRVdzk9KlklOVdrZqpMvO4VoTDNU7gYXj9KAZAWOMVBI+01IemRUDHIO7g0hNimftThLUZACZFRGQA4PWgEzSgfCk5o8z5TjqaoLKR0JwakD4BzkUBcdIQeSOKzp5i7hAeKsSPuUgnFVXUKCemKAZNqd213IrM2RGgQZ7LWTLLksM5NEkpZyD0PBqvONsjHB5P60GbdyvcSYyM1UdjgNUkpYyZPWq7ZzjHTmmYyZYt5AAR61dhkUkfkKyoW+Yg4J6c1diycbvXikxwZpqCTn1Hp3qzFAZeMZ4pdO2hBkZPvWzCgyOKDdK5mQ6TLKyr8qgnnJrqE+yaDYbY8PcPyW9KqjEKlu/UVgXtw8txye9BT91F1rl7icsxJ56muh02XFptY8+lcnbkKSOprVtJiqHHAx60AnbUuXTIjHJrF1a4BgbynzkdjWZr17IGYbuPUVz8d+6yYLEgdQaPQznUS0KGoTvvZDuwRyT29fwrnLptuQa3NSHmuWiOC3Va567U7iG65rR6I8md3PUhzzSEAgmoC+D7CrUJjK/M+KyTuaNcquNJGDxSCrRSL+F9w+lROABxVWIv0IGPFRdfzqdio6Cm8EdBUs0TsQ3J2JnuayZJfnNaN6dwA6VQYLu615+Jk3OyOuglbU+/JWO41AzU6VvmNVJ/PLxiAxqu75i+eB7Ad/yr1TvHu2DSK2RSOMn0oiQmgBrrmoZIwRVt4z1FV3HWgRmXEQxjAqrJaKRntWpKhPaoJl46UmIyprTjis+ayJBArYmcrwRVSeUhTgUtBMxTYy89OKqy2MvNa/2go/qKc8yt1WkKxzz27jHGaY1uzH7prXnJ3Z4xVaWfavb8qQrFNIZQPu9KcYXI+7ViO7IGOKimvSi5wDQGhCbV8HIwarTwPsOWAPekl1Jy+APpVKe+YkhgRkZoJbQxoFBO5s/SnSlHgUBAWWqrXAK5H86hWcqxHTNBLa2Kl3IqOduBzVX7Rlcnrz2pmozbWLEcg8gGs+OXzHYBhjtziqSOSdW0rGqgVgSmQ2asxSjPpVawHy8kkAUyWQb8jpmkzRSsrnRadKOM10VscqDXB2V20bLnlc5xmuss7vMY7ik9Dopy5kalzJlP0rIli3t75q8H81MYOKj2bWyBQXuMitmJGQR6mnyOIx5YarNxItvbFm4JFc3dX7s42gAelAm7FPxE+1x12nOTXJXMjeaCM+hxxW9rNyTFucnA6isLYJUDKeeucc9ferjpqeZiW3KyKs0zRSEISMVSuZRIfmPzHvV7UIvKkJY53HPSsaeUbjx+VKcrIxhFt2KtyNh4qNH46/rRcy5U1WBOM54rzatXllod0Y3WpbiuShHWr0UglXOax34GQcinwTmNu5BNXDEcr5ZbEzo8yujSkUjpTASARUsLCZeoJ9KSVNp6EV2W5tUYJ20Zn3TcmqeF/iiDH1J61cuz81Z7ZLHOK8yprNs7qOx99yfeP1qM9akcfMcetRmvYOx7jSBmnIcd6jdgvUioWnUcZoEXhJxzQURh2zWTcXTgL5QBJOCSeg70gvCOmaB3NCS3FU5YCM8UiX5YYNP+07ue1GgjLu4m/wAis64UgdMity4lRjjGapXBTZ2pOwmYcsYAyOtVJiUrTuNg6HjNVJgrelSSZjyMzYNVppMnPpVyePawOM1RnjIU4Un0pCZCZsGq003zEEcUMkhU4VgailVwoJBz70E7Fa44bjIx2qnI5JI79qmnLgngjPrVZ8A5JAoRnJjdy7Tz0qF85zn6VK5j2gBvmNM2b8j2yDQQzJv1DMeOvr3qsiRiZCONx59q0Zk3nJHPcUw26mEbT8wOatM5JU25XHPKIol2jBNVml3yckkAcfWoZ2J3bgSB0qGKRkYjJx055pqOhEqvvW6GlHIFHQg571t6VdgZTqPftXP+YMDDDGOKmt7gRyL82M1DR0U6nKz0C0mDLj2q7BGGcsxwijJPpXPaTOZWRVOSSB9a1PE939hsUtl/1so+b2WkjucrK5ja3qX2i4cxt+7H3celYaXRMgHUg1DLODt7E9Aah8wLknAxzimlc5ZVSTVsSg89ulZungCQ5zgCnT3PUDHPT6UkbqoLNkM3vVrY4pyU58yM/wAQznzcVzruc8GtfVm8wljk/WsKQ46GuPEy5Taj7yuDDIIz+FQv8oHQ5pXbjk1Cx5561582pNHXFEkZJXGDxTWwHHHGe9MU4BJz1xT8ZbND0XoVsXNPm2TLk8Gt66RfsySDqeMVy6ttP48VtQT+ZAOeemK7sJUuuVnJXhqpIyrtiWxxzVYAHqy5q9eJuBIxWaWjBO5cn6muaqrTZ10Wmj79lIDNn1qnPP2FNuZiztz3qs7d69c6WxjOSeaidjTutMkHBoAOGGKUJgUkYJH1qQDI60WEV2G3movPZTjtUk316VWYFicE4pNASMxPOapXJOKezlGP92myfvRkUhMoyEbeveqsrbT8vSrU6qpNUp3JHApCK0755NVJJ/yqSYnv0qhcEgn6UmSxWnYN6Urzq6EYAaqbSbs57e1V3coSaBNkd7KrZ55IP41juMtwc496tXe5skVTYDOTkn1/rQjCbuydMlecccUqthWKnkVHEAQfm5NSxxg5I696YJ31KuQMsVPPSpoArRlSBkZ/OmzpsGTx7VGshDYA6dqCL2dmZupJiXIJGeDVAcl8cLnJrY1GNZUO37wrIkJ2lgQGOcitE7o4KsbT12J4ZNwGQCR6epp0khUtnj29+lRW5RELAlueBjk8Ui73dRnHQ8d6AbasjuvBWJnEr8CMbifTFReJ7s3bvPkkn+XpVe2u10zSgudskx2k+1U9Ql3246dKzW56MnanymHLdGQkAckd6RZT5P8AER69zUMqBd3JDdqYHHzB27Y4AGa1Z5ik27yZLJIBH/FkgYPpUTuGTcWwQcYJqKSQn1A7Akn+dV5HOT60tgTvoRXblg2T/wDrrHuB8+AQO1aUr7geKz7kDdkd64sTa1zroKxVZeBzznjJqJzxx1NOkJwDTE5zleteclfU7lsKnIAJAxknNOV/lHYmon+bvkmliO0EsBjir01voU1dD3fB7YqzazHd14NUt2WIGP8ADmpkZUGcinBuLuTKN1YtzN8hGazHGGPAqWSYK55/KkZ1Y5HTAoqS5ncKcXA+5Zj+8Y+9QOc0+QgyN7E0xq9k3bGq2BSNyPrTQATillOMCgLiowUmlZsDiqwJyaGbKntxRcLiSvknmoWIHamsx3fNURfJPPFTcVxk+R1NV0lYNjtUtw2RgdaqTNtHXrSbFcnkZTzjrVedF2ZxUXmbh16GllYlORmgCjMoYkKMVnXEWAc8mtGT5gccVnXAJBHJpCKUjAKVxVOUHbgCrwXBOeaqznaeMighmVOWXAUYJqqxYsRWnKC7HjnFU5YzuOVxTRjJEFsdzDgD2q2xAUYwM1XVPLBOOBzU+d680mC0Vhl0GkiDfL5YOMcZFUCreYCvQirsyhrd1PI9qqF9kfB6cU1sZT31GzZ2nj5sdjVD7M0gYncSBnrUpnO4gYzTd22UEdCOh+tXHQ552m9SJbVowucYJzVzTbRGuPMY/Io59KdAPOIGOM8U/UdthZqqtlpOfwou3oVGCj73Yp6vdb7qIBsxo3IrRm2tH247VyV3MSCTya1/tbSWoYHGVwf0qba6CjUupOXUiuCod8qB/WqTuMDAxinzSbjluwweKpFzk/yq27HMlzE5YZ5x+FVpmHJ7Uu88nNVZnO0j3qJS0NYQ1Gyv6dKp3LcZqSUngDkk8VVf5gO/WvOr1b6HbTgQO7bM8Y701WYgHjp1omf5jgZyOfxqNZSCSwOPSudLS/U61G6HCRkKk5APQgUzf0OSBn6UM27GCR2AHNNyOVViQOhH+faqSTZaRKoC8g801yPlAPFKyqqrzgkc5HWo3bIKkbhnI4q0u4JajnUsTn688cUixOwBVVIPfikmLMWkCdxnHvToxAUBZn3d8DipsUkfcbn963HekY8fjSSsRK/Pc1Hv5r2ExND145xUNzJgdOacH5xUU2GzzSYIiWQdWOM08SK3QZqo0bHpUsKEHrQIWRQ3OKqyNtJUVf8AKJGCKY1uuTRa4FPYWXOap3EWTg8mtWRNo47VQlyOoqWrCaK8ca45qG6baAKshOMmqN02WI9KAKMznGVPIqIsGHOc0+VT09elQkMOCKRJWmX5+D1qrKmavlcnmo/KGSSMUCsZewh88kCmyRhstyDVyYbWPcd6pXEuEJwcUEtJFWVfm4xj0qFmKLke9TRqWIIPFSeR5xIAAxnGTQjNq5SLMIy6/NzyKqXriW3jdRtIbYcDvUrP5Eu5xmNDyv8AeFU7VlnE8LuFjlYsp9D6VaXU55yv7vqZrSMCQSCBxipmkJmQKMdPfvUAGZPKOBJnHIqVAVAyy4Dbc5q9LnDHmasbmnR4bLEe/viq3iD51BbgA8E1LYzqRzge1JqsZkj3Kc+gzWa0Z31Fek7HHzqQcH6Vfhl8u1EbDLHBGaS7jV5flUgk49vwpzpmIAnDgcfTNUlZnFe6Ksz9yeaqNJjPNOunIyM81TaTIFZVJqLNacLq5OX4JqCRvemNJwc9KrzSkngY/wAa5qtVI3hTGynkY5qtK2BuJ4p0hYq5OMjA5qvM+0Y9a4filc7IQFIA4J5NMkII+Qn0weopg7g9e1Mx+8AYZHQ4FXFanRGJIGxljx6AfzpEJBBHRTwKamCDuBpoBY/LwKdu47Ez/ewWBxTTwOo9RUYBJbqKcFJK4xkc0LRhZD8fdJztPLADpULqVbAlGPxqQuxVR1B6ZHT6elHln+Lr7mnsNaH29K+Xf1yaiaQg81WmlxO/pu/rTXkPbpXq3M2yyznIOaepznPNURKDwakWUA07oLlsY9KkTaO1VFlGKcGyetJsEy5xTHIxUOcVGzHBAxzQmO46RgaqSx7jnsKmVscZzUcrjB7mgRnzEg8HpVZxkHd3NTTqzdqYEGzGc4pElKUZPAqEqOcCrcp2jA71RnY80mDIpGx0FRHLDrxSSMQKiORzn8KBMhuF5xWXOpXduOVzk5q9d3IUY6nFY167uuKEZTdkKLhRIAnb07UktyWl+TIGOaz5m8td3GDycVGJiY+uCf5VXLc53VtoSagxJLK2CccVlI5S4UvnCnn25qSWU7mBfgfzqrcOM5U9uetWlY45z5pcyJ7x7aS9M6PtRjyuORiodQhe3ZGVyyMNwOaqMc57Ve02Vrho7FyhR2ABPbn1/Ok3Ycff9Sit5MhB80jmtuw1P7QnlyY8z/0KsPVLc2eoXNsWVvKcrkd6ppLtIxwahs1i5RN+5j2TIyjCk0syeZGrIo54PPNR2F39sjCtjzV5H+1WhaKNx3gbVrS90Z+z1sjn9ZiAlOBh/wCIViSHbxk1q6tL5l3NIOBnoKxLhsk1w4l9jooq4ruOmarySDsD060kjYIA71Cz8fMOvrXFdtanXGFh0gOGJ4C4696jmcDAYDIPUDJAprOCT+P4VFKeWMeOnJB7VaVjojEeOYw2RnPT2pJSXK4OMdR0571EpGRnBX2zT0b5SFYjIwPp70bGlrDlyXyWAVTnGAf0pX+YqQMvjnFRuFDLsbOQN3NNZgFO0fK3UDvTbuFh6bhuVgQc805MrgFyOc/4UwE9cA9vxqR+COBjr17VKV3oJoUlT8u44HJGeT+NMfLsWdyWPfHWlk+ZW2jGPf3qtvJ5PWm7vQEm0fad1nzX+p/nVdpMcVJcN++k+p/nVcnmvUMWOEhzxUiucVXU/NTy/NAEhdgeOhqSOU8cmqnmfNjvUsZJ6UDTLZmNNaUn3qIc5qVR8ozQAq5PJpH4FOOFWo3OaAInI24qsy9SDVpkBFVpkwpwaAsUpeSaqT7NpJPSpbt9i5Y4rEubr5SB0PvSZLdhZruJeMc1SnnLnrj6VWlcs3A71GDtOO9Bm2Ezg8nNQy8oecCnSNkHGAR7VUmk9+PSi1zOTM644A3n6VRZssWUYPXGauyusuQVPscdaqOiRvhjxznjtW0XY8yqm3psRMysBu4JPXPQVXlGCRnPvVgqGBVduCSc+npVU5PA6UMghP6U+J2idXRtrDkGo5DioGdhn0qGzWKb2FuCZJGdmJZjkk1Ubg1KWznPSoZHGME1z1HpodEUWbK4aKdHU9DXZXBVbSSZeEKbhj14rgEY+YtdZDOZNAljP3oyOfYmqozckU1a/oc/M25mPUGsm6yHYHqK0pCA5Izg8/SqGoJgiQHrWGIV1fsy6Fk7FItj5h2/rmmFgckc4pOQBknn19KaVXPDHdnHPAxXM10O9JArfd+UEnII+vFQAMB0yx5+9mnyNnZtycnGOaTfuj3F13BQoG0/596a2NorQSTp6HoR6UgTknJ2D880illbJ6sMDGacd0fIYbjnqeRxRbULWIlB35zjPapiGJCpy2eV/GowGBDDACntT++UG09QB2oY2KhwNu3DDJ+lJIW8veFJ5x/n9Ke7fKmAASOgH+faguwXaCduMY/Gkt9SVvqMkAVXOSvU4I7+lLBJmJd0MmfpTpCWQktluOCMmoC3oGpqRUbWPsu6P76T/eP86ql8dRVi5P76T/eP86rFCa9M5mNMmDwKVZGPNMC8kEUuCCaAHBsMc9amjbsKijTceanQAHAoBEitt681IHz06VERxSKccUDLG7PJqNjzSFsimFhigBxbiqtzJtU1LIwAqjcyZo2BmRqUxPXoKx5dvJJ59K1L8BuorKmjCxsc8UjOW5XMi7STxiqcxPBByO1TgqVIODUMwwODjNCMm9BjEBQWOSaqlwysDwRT5GwOp45+tU5ghkB3hW+vWqSMKkrEUn38AYC8/rVKaUFVUr0/CpJhtjy3bvVaSRDyrHd6dMe9aHDJ3B2KjAyAev61Xkfn3oZsjlifQ5qvI57UmwSuxZTmqzsM47Z4+n+NSFs8VXlXBNZSZvBCHIJqFxmlPGaid8DGetc0pJG8VroIww4A6elbdvMywMARtcAHisBeXLMcHtV2zugF2OfpUYaoouz6jrQbWg64QoahkTfCc8gVckZG5zmq7MqowJGK1mk9b6NMiDZhzoQWAGSP0FQuGIG0dCCTjmrV5Iu/C8+v0qnvO9mVML+eBXFG/U9Wndq4x1zgjofSnnhdw5GSBjrSqDtADENn5RjqPXNDLjO/5QMj15xTNLdBJ1ESbSSW4wVPABHP401pCFK8jPUAdfrQhHynBxnOc9KayttDY69O9MY9RlXCgEdieOM0kYZWAPGR0oiz93rnp71JLlG+bKn3+gpO4hgH70k5IH6inA5ySeTzz1pEPXI60rABhlhg96TJYjKVZX5Ktkg464/pT1WIrkuQe42jg0yYoqcfMc9evFROY93DgD064p9CrXPs+5VRLIf9o/zqsx64qa5fM0g/2j/Oq4Uk816hzsTZk5AzS4AHPWplUAVHKOcigBoOKdGeRmoBndUik5FAE7YpFwDnpnpURYk80ZNAXJGbB9qjdqZIeOKhdz3NAXJJZBt5qjKSSaWaTPvVZmOOtIGV7tdy+9ZNwPkIxjIrVmbI96z7lQQfWhktGVKFVTntVV/mJ5qW9UqxGfyqiXK8N3NNI5pySYy6cqRjoOKyXnB+bZl+pOe3FXr45TjOf6VmkhQccEdGA6c1pHY4K0rzsNluW3MD90k/lVPO5iKlkXLHGdvbI9qbjBGORQRcQqSvTtULgZqwzjoSTgfriq0jZ9TSY4kMjYzgVAWz17d6kf071XckcDOPSuebsdMEMcntVeUE9DjnmpzkjJ4qGQ4HFcdRo6IaMgJxwRikTJOSeh4pXbcv+etNDqFA71h1NraFhZSgwxqKa63KVjBPrVZ3Bz1JFRPuAxjFUnK2pcaSvdjyNxVtp5yAc96rysRHsXIB689fSlcDKjDD5cj61G+Nu3IJIP6VUV0OmKAIN7K42soAGDx+NCSFF2HJUZOKYoJJO1mIyTz2p0KhySN2VGeuMVVjSwjcIB1Oc881PHuKSOY8IoGcfpUMpUyFcYA6Zp6kruLPgE4bB60MW61BZMHCtnjA9qQ/Pt+dyQcDNKFXcpibHy4YZ79/wpB8ijnA9+9NbiemxIhWOQEoCPqfpTyybVG1WPSmFAVJB+8cAd/rTZYlDD5x6kVnuT1FU/OSVBxycjioSwBwvT6D+oqRk3bvmbsozzmmbH7NjHHAq0XE+0JkHnSH3P8AOoWxnFSXDYmk/wB41XY8e9ekczHbsDio3JNLnio2JxQIAAKXNQs/HFHme2DQBISKAwxUBP401mC5yaAJJZMCqskpJIBqOWUnioGfgnvQDY+V9vBqu8vzGo5JearO+ec9aRLZJLLVSaTrk8052yPeqsp5JyaBNsoXx4zn86zVQuvXJz61o3WScY4x1qj5LKQckCqRyVNyndhlXJOSAaou3DAKpU4yfWtG6K7cMOvcmsudlzwpBxVrY4qvxaFaRgrEgY9qiMhHNJMcjioSecHpUtijG6HyPz0qLzAKjlOM88VXdjmspTsbxp3LEhz0qu2O9LuJFRyfSspyumzSMbaEbscY7VA5PIJBxT3bngZpjEqA5HynpnvXBN3ep0xRXJLA7Rn19qjB4GGGT1AqR8HcM4BqDdtJTCjPGevSmldHTFXWgq/KNzZwGAz+tMdhsOf0pXwVXOc4zx3pjxlkB/hOf8/rTa1NLDnBK8jGOelQoxJUHbgHOT39qkbfGoJOT1GfTH+eKgXh8sCB1/CqSNIrTQcx2udpB45xxjPamJuLADHTjjrUjBTEnBUkcn171GFUK2M7zgLTRSHkhyOAducGnKVw24A5HX/PelRQ23JAx6AnB9f5ChUxDnPPQjsOaTExgUBR/hThiVwAAABjJYnHrmkJHO4ceufalRG5YfMBknP+fcU7CHK/ykcD8KjdS24rzgce9PkMkr4JDM3Oc80m3PBPHsOKlaC2BWbyyG5zjt0/Go3LKxHP4jFSANISFDEjuOajkjfeQQ+RxwM073HE+x7qTM8mP7xqt5nXNLcv/pEo/wBo/wA6h3jn0r00czJhJTZHyKiLD1qOR8HjFAA8p7UiNk0wjdSbgqn1oFckeXYOTVR5yWOTTJ5s9+aolmLHH4CkJstvLUJlPPNQSOeKjdvrQK46RyetQu5xwaZI/wA3SoWcn0xQJslD4PNQyv6GmZwT+VNdlUE+lBDZFITuyelU7i4CkhuB2qW4uAvI6d6zb1gxP+10qktTCrOy0K15NufCgHg8+lZtxIXUFiPyqw2FUHPbnn9KqXBJY/MT6dq02PPu5O7Kzk54qBweO1TEcHvUL9Kyl5m0SB2Geaic7gKWQAZ70xTz0rlcrnSkO3YFMYjHPrQRlcVA5G7kkVjObWhcY3EduvpUTnOc96dJtA4znPX2qBjkbQRmsNXudEUK2wNkgEYx+lVXA3dvSpnjC/xf5zVZl7knPWmk9jeCHhgEYDABGOvSkV1ThiTjjaTxSqmxw6kEMOCTjrwf8+9Rqi7vnBHJyBzjFVY15Qc5YgkZPIxTQxC7tp+o4wKXu3y4HPfntxTWkdUOCWOe/NNFIVmBG4Db6igqpWM565wMf54qPJICBSc89KlCsitvO44xg/w55p2sO1tQJXyipBLEg56UBN25Wbgd896hAw2M8delTLuYeWBg5yT0NLYT0JCwbeB1xw2O+e1MgkYEYJ46kdacoILAgBSBjnnpTGXywdvJPpSXYnbQfFjcxReD91SM9+lOyOO+PwqJF8sAuDnqMYIxTmRMhvm25xjPNOybBrXUbgA7snJ60m8kfdX060+4dchY42AJ79fSqrFCc4NCuVFXPru7f/SZf94/zqEPTb1z9ol/3j/Oq4YmvTucjvcstJz60xjzk9KaeKguJCDgdKLgTGYKcVWml3ZwRVeRjjqarmQ5wfzpXE2WJG49c1Czj8qashYsOwqKRvmX3oJew9nO3Oagkk496cz5XpVaVuec80Et6D2fGOck1Fgl+/rSEgKBjrio3lK9KBLclkcJ3qnLJnOKidm3kZ4qJ5MqOoxxVWMpS0I59rbgxxWa8pDYUnA4/WrszAEtg4yMD0qkVLtnOMg/lxVo4arbasQT8sAD1Gck1Vlx/Ccj1qcpy3sD+lMniCZ5z/8AXoZmihK20GqjSEk+lX5IwQfTpVR02k4xzWE0zoptFc45zUQBznGRVh1zzURAAIrmqRZ0RYxz7dKrv0Gemask8GqrnccYGcVhNN+hrAjdSOPSoJSCOCcjrTyQXAOSabINzZXjqaziux0RVhhbjBB4pgC7FYfeJIGfSkz8pJJ+X/GmM5B46e9VaxslYlkxGcAqQevH0qLOQxUlSOmO/wCNMV8jBz69fQUhJCBmJIIzgfU/4U0rGiViZhkKcgZHX+p/X/Co3fc7IOSMkcds96RZMn5QccjB+nNOMexkOclgCvNOw0iKNFR3ynU8MCeKmRgpbcARj+LPJqK2zcPhT1yeeOlPidWD4X7q/nTd+o5X6jYmkSJMgblJOfapCWLltx5ORnr9aR2JCEY3PnIxgdcUyTIXcT17Undid2BO7IHf1oI2qqnG5jmnOQGAI5H8vrSF8sJMDeDjpxQtwRJGAGDIRketMLMzYAyc4FOfCwqWHJXt6Dj86aWA3MgIXHHPIpE2CRGCkE7fXmq/XkgD2qVFaSSTaQHxkH3FVNw9D69atI1jHQ//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Angiogram of the left cervicovaginal artery on a 55-year-old woman with chronic vaginal bleeding due to cervical cancer shows moderate tumor staining and neovascularity in the region of cervix.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19168=[""].join("\n");
var outline_f18_46_19168=null;
var title_f18_46_19169="Meibomian gland dysfunction 4";
var content_f18_46_19169=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Meibomian gland dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Expression of a solid white paste from blocked Meibomian glands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gary Foulks, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19169=[""].join("\n");
var outline_f18_46_19169=null;
var title_f18_46_19170="Algorithm for management of rotator cuff tear";
var content_f18_46_19170=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78386&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78386&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 627px\">",
"   <div class=\"ttl\">",
"    Algorithm for management of rotator cuff tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 607px; height: 784px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MRI: magnetic resonance imaging; NSAID: nonsteroidal antiinflammatory drug; PT: physical therapy; RC: rotator cuff; US: ultrasound.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19170=[""].join("\n");
var outline_f18_46_19170=null;
var title_f18_46_19171="Hydroxyethyl starch (tetrastarch) 130/0.4: Patient drug information";
var content_f18_46_19171=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Hydroxyethyl starch (tetrastarch) 130/0.4: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/60/30661?source=see_link\">",
"     see \"Hydroxyethyl starch (tetrastarch) 130/0.4: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/21/11605?source=see_link\">",
"     see \"Hydroxyethyl starch (tetrastarch) 130/0.4: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10074407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Voluven&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10074408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Volulyte&reg;;",
"     </li>",
"     <li>",
"      Voluven&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10113101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691514",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat low blood volume.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10113099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2722827",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tetrastarch or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703338",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding in the brain, high chloride levels, high sodium levels, very bad kidney disease, or a very weak heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10113247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10113249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10113253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10113245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10113257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12320 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-110.124.11.8-587BC34546-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19171=[""].join("\n");
var outline_f18_46_19171=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074407\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10074408\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113101\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113099\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113247\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113249\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113253\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113245\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113257\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/60/30661?source=related_link\">",
"      Hydroxyethyl starch (tetrastarch) 130/0.4: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/21/11605?source=related_link\">",
"      Hydroxyethyl starch (tetrastarch) 130/0.4: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_46_19172="Dornase alfa: Patient drug information";
var content_f18_46_19172=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dornase alfa: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/13/29908?source=see_link\">",
"     see \"Dornase alfa: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/35/26163?source=see_link\">",
"     see \"Dornase alfa: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F161836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pulmozyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F161837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pulmozyme&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691351",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower the number of lung infections and help lung function in cystic fibrosis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dornase alfa or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to hamster products, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697968",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in voice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694871",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow what your doctor has told you to do.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For breathing in only by a puffer (inhaler) or as a liquid (solution) by a special machine (nebulizer) into the lungs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696369",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor will teach you to use the nebulizer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694734",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not mix with any other liquid drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in foil pouch until ready for use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699642",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use right after opening.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use if solution changes color.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away unopened drug if left at room temperature for more than 24 hours.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12394 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B09A38F648-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19172=[""].join("\n");
var outline_f18_46_19172=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161836\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161837\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029417\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029416\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029421\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029422\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029424\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029419\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029420\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029425\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029426\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/13/29908?source=related_link\">",
"      Dornase alfa: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/35/26163?source=related_link\">",
"      Dornase alfa: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_46_19173="Ifosfamide: Patient drug information";
var content_f18_46_19173=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ifosfamide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/25/38297?source=see_link\">",
"     see \"Ifosfamide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/33/11800?source=see_link\">",
"     see \"Ifosfamide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F181779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ifex",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F181780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ifex",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3756505",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause blood in the urine and bladder pain. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700695",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause kidney problems in some patients. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700335",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause hallucinations and confusion. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702289",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ifosfamide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pass urine often. You need to empty your bladder often. Drinking lots of liquids will help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024131\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698220",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count or low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697974",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Confusion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10755 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.96.59.103-08F48505D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19173=[""].join("\n");
var outline_f18_46_19173=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181779\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181780\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024124\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024126\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024125\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024130\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024131\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024133\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024128\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024135\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?37/25/38297?source=related_link\">",
"      Ifosfamide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/33/11800?source=related_link\">",
"      Ifosfamide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_46_19174="PHACE syndrome 1";
var content_f18_46_19174=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F70599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F70599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    PHACE syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This full term infant was diagnosed with a non-critical coarctation of the aorta when she was&nbsp;two years old. On the third day of life she developed an extensive red mark on the left side of the face extending into the scalp.&nbsp;A brain MRI/MRA revealed multiple intracranial vascular abnormalities. These findings were typical of PHACE (posterior fossa malformations, hemangiomas, arterial anomalies, coarctation of the aorta, cardiac defects, eye abnormalities).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Albert Yan, MD, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19174=[""].join("\n");
var outline_f18_46_19174=null;
var title_f18_46_19175="Evaluation and management of condylar elbow fractures in children";
var content_f18_46_19175=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation and management of condylar elbow fractures in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19175/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19175/contributors\">",
"     Leticia Manning Ryan, MD, MPH, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19175/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19175/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19175/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19175/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/46/19175/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lateral condylar elbow fractures account for 15 percent of elbow fractures in children [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Early recognition and proper management is essential to avoid elbow deformity and functional impairment. Medial condylar elbow fractures are rare but need to be differentiated from medial epicondylar fractures to ensure proper treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Unlike supracondylar fractures, condylar elbow fractures rarely result in acute neurovascular compromise.",
"   </p>",
"   <p>",
"    This review discusses the evaluation and management of condylar elbow fractures in children. The evaluation and management of supracondylar, epicondylar, and transphyseal elbow fractures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=see_link\">",
"     \"Evaluation and management of supracondylar fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22663?source=see_link\">",
"     \"Epicondylar and transphyseal elbow fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lateral condylar fractures account for up to 15 percent of all elbow fractures in children [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The peak age of injury is six years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/5\">",
"     5",
"    </a>",
"    ]. Medial condylar elbow fractures are rare (&lt;1 percent of all elbow fractures in children) and typically occur in children older than eight years of age in whom the medial condylar epiphysis is seen radiographically [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general anatomy of the elbow is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19607?source=see_link&amp;anchor=H2#H2\">",
"     \"Elbow anatomy and radiographic diagnosis of elbow fracture in children\", section on 'Pertinent anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The lateral and medial condyles of the elbow extend distally from the relatively weak supracondylar region (",
"    <a class=\"graphic graphic_figure graphicRef66099 \" href=\"UTD.htm?29/25/30111\">",
"     figure 1",
"    </a>",
"    ). Fracture through the lateral condyle can extend into the capitellum, disturbing the articulation with the radial head, or into the unossified trochlea, resulting in elbow instability (",
"    <a class=\"graphic graphic_figure graphicRef52534 \" href=\"UTD.htm?35/10/36004\">",
"     figure 2",
"    </a>",
"    ). Medial condylar elbow fractures are the mirror image of lateral condylar fractures with the fracture line typically ending in the trochlear notch (",
"    <a class=\"graphic graphic_figure graphicRef63785 \" href=\"UTD.htm?22/52/23363\">",
"     figure 3",
"    </a>",
"    ). When displacement of the medial condyle occurs, the elbow joint also becomes unstable.",
"   </p>",
"   <p>",
"    Ulnar nerve paresthesia is sometimes seen acutely in patients with medial condylar elbow fractures. Otherwise, condylar elbow fracture patterns do not usually lead to significant neurovascular impingement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A fall on an outstretched hand is the typical mechanism of injury for both types of elbow condylar fractures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lateral condylar fractures occur after a fall on an outstretched hand where lateral force to the forearm puts varus stress on the elbow joint. This stress causes soft tissue structures (eg, extensor muscles and lateral collateral ligaments) to avulse the lateral condyle (",
"      <a class=\"graphic graphic_figure graphicRef53336 \" href=\"UTD.htm?36/46/37605\">",
"       figure 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3\">",
"       3",
"      </a>",
"      ]. A lateral condylar fracture may also result from a fall on the palm with the elbow flexed. In this mechanism, the radial head is driven directly into the lateral condyle [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3,6\">",
"       3,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A fall on an outstretched hand may lead to shear forces on the medial condyle applied by medial extensor muscles and ulnar collateral ligaments (",
"      <a class=\"graphic graphic_figure graphicRef65109 \" href=\"UTD.htm?22/59/23479\">",
"       figure 5",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3\">",
"       3",
"      </a>",
"      ]. Medial condylar fractures may also follow a posterior blow to the elbow. This mechanism drives the olecranon directly into the medial condyle [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PHYSICAL FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The child with a medial or lateral condylar fracture typically has elbow pain and swelling over the medial or lateral elbow with limited range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/8\">",
"     8",
"    </a>",
"    ]. Careful assessment for open fracture and neurovascular compromise should occur in these patients. In contrast to supracondylar fractures in children, serious neurovascular injury is uncommon with condylar fractures, although medial condylar fractures may be associated with ulnar nerve paresthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation and management of supracondylar fractures in children\", section on 'Physical findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the initial evaluation of the patient, the neurovascular status of the limb should be reassessed after manipulation or splinting of the fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographs should be obtained in children who present with localized tenderness or swelling of the elbow and known or suspected trauma. Condylar fractures typically require four views (AP, lateral, and obliques) to be fully characterized. Comparison views with the unaffected elbow may be helpful in children with subtle fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19607?source=see_link&amp;anchor=H8#H8\">",
"     \"Elbow anatomy and radiographic diagnosis of elbow fracture in children\", section on 'Plain radiographic views'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lateral and medial condylar fractures have characteristics of Salter-Harris IV physeal fractures because they extend from the metaphysis through the physis and into the epiphysis (",
"    <a class=\"graphic graphic_figure graphicRef79444 \" href=\"UTD.htm?26/18/26918\">",
"     figure 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/5\">",
"     5",
"    </a>",
"    ]. Growth arrest is relatively rare with these fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=see_link&amp;anchor=H15#H15\">",
"     \"General principles of fracture management: Fracture patterns and description in children\", section on 'Physeal fracture description'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Condylar fractures in young children may require magnetic resonance imaging or arthrography to differentiate lateral condylar from transphyseal fractures. An understanding of the ossification anatomy of the elbow should make the distinction between a medial condylar and a medial epicondylar fracture obvious on plain radiographs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19607?source=see_link&amp;anchor=H17#H17\">",
"     \"Elbow anatomy and radiographic diagnosis of elbow fracture in children\", section on 'Further imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lateral condylar fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A commonly used classification system categorizes these fractures based on amount of displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stage I &ndash; Displaced less than 2 mm (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73014 \" href=\"UTD.htm?30/61/31697\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51977 \" href=\"UTD.htm?10/25/10644\">",
"       image 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Stage II &ndash; Displaced 2 to 4 mm (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60788 \" href=\"UTD.htm?39/23/40304\">",
"       image 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Stage III &ndash; Completely displaced and rotated (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81394 \" href=\"UTD.htm?23/29/24031\">",
"       image 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Milch classification system is also used [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3\">",
"     3",
"    </a>",
"    ]. However, poor correlation between the preoperative radiographic diagnosis and intraoperative findings using the Milch classification has been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/11\">",
"     11",
"    </a>",
"    ]. Milch described two basic fracture patterns:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I &ndash; This less common pattern involves a fracture line that passes through the ossification center of the capitellum and enters the joint lateral to the trochlear groove [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Type II &ndash; This more common pattern involves a fracture line that passes medial to the trochlear groove. There is potential elbow instability because the radius and ulna can displace laterally with the fragment [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Medial condylar fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;These fractures represent a Salter-Harris IV physeal injury (",
"    <a class=\"graphic graphic_figure graphicRef65109 \" href=\"UTD.htm?22/59/23479\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef54582 \" href=\"UTD.htm?20/55/21361\">",
"     figure 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3\">",
"     3",
"    </a>",
"    ]. They are further classified as [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Type I &ndash; Greenstick or impacted fracture",
"     </li>",
"     <li>",
"      Type II &ndash; Complete fracture with intraarticular extension but minimal articular gap",
"     </li>",
"     <li>",
"      Type III &ndash; Displaced and rotated fragment",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate therapy consists of pain management, application of a splint for comfort, and elevation of the arm above the level of the heart [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/2\">",
"     2",
"    </a>",
"    ]. Orthopedic consultation is recommended for condylar fractures with &gt;2 mm of displacement to determine appropriate intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Analgesia and immobilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children with condylar fractures, initial therapy consists of pain management and immobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parenteral analgesia (eg, intravenous",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32233?source=see_link\">",
"       morphine",
"      </a>",
"      0.1 to 0.15",
"      <span class=\"nowrap\">",
"       mg/kg,",
"      </span>",
"      maximum single dose: 10 mg) is most appropriate for initial pain control in patients with moderate to severe pain and should be given prior to radiographic evaluation. Oral analgesia (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"       ibuprofen",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      may suffice for patients who have suffered a nondisplaced condylar fracture. We suggest that the clinician avoid the oral route for patients likely to require sedation or general anesthesia for fracture reduction or repair. In most circumstances, pain relief will result in an improved ability to assess the apprehensive child.",
"     </li>",
"     <li>",
"      Immobilization enhances patient comfort and prevents further fracture displacement. The arm should be splinted \"as it lies\" (typically with the elbow flexed 20 to 30 degrees) using prefabricated splinting material or eight layers of plaster with under cast padding (eg, Webril&reg;). A loosely applied elastic bandage (eg, Ace&reg; wrap) holds the splint in place. Neurovascular status should be checked before and after splinting.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Orthopedic consultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt orthopedic consultation should be obtained in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Condylar fractures with &gt;2 mm of displacement",
"     </li>",
"     <li>",
"      Open fracture",
"     </li>",
"     <li>",
"      Fracture with neurovascular compromise",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Definitive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive treatment varies for each type of condylar fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Lateral condylar fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is guided by displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/11,15\">",
"     11,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage I (minimal) displacement &mdash; Most minimally displaced fractures (&lt;2 mm) can be treated with cast application and early follow-up (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51977 \" href=\"UTD.htm?10/25/10644\">",
"       image 2",
"      </a>",
"      ). The elbow should be casted at 90 degrees with the forearm in pronation. Since these fractures can displace over time [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/16,17\">",
"       16,17",
"      </a>",
"      ], close, serial follow-up by an orthopedist with pediatric expertise is stressed. MRI may be a useful tool to further evaluate fractures to guide surgical decisions [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/18\">",
"       18",
"      </a>",
"      ], but it is not routine. Operative treatment consisting of closed or open reduction and internal fixation is performed if displacement is noted in follow-up (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73014 \" href=\"UTD.htm?30/61/31697\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Stage II (moderate) displacement &mdash; Closed reduction with percutaneous pinning or open reduction and internal fixation may be employed for fractures with 2 to 4 mm of displacement (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60788 \" href=\"UTD.htm?39/23/40304\">",
"       image 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/19-21\">",
"       19-21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Stage III (severe) displacement &mdash; Fractures that are &gt;4 mm displaced",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      rotated usually require open reduction and internal fixation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81394 \" href=\"UTD.htm?23/29/24031\">",
"       image 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/16,17,22\">",
"       16,17,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Medial condylar fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I (greenstick or impacted) and nondisplaced type II (intraarticular) fractures may be treated with cast immobilization with the elbow in flexion and the forearm in neutral position with respect to supination and pronation.",
"   </p>",
"   <p>",
"    Open reduction and internal fixation is recommended for displaced type II fractures (medial condyle displacement &gt;2 mm) and for type III (displaced and rotated) medial condylar fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initially nondisplaced lateral condylar elbow fractures are unstable despite adequate immobilization by splinting or casting. For this reason, orthopedic follow-up should occur three to four days after initial care [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/5\">",
"     5",
"    </a>",
"    ]. Healing of the lateral condyle can take longer than other elbow fractures, and pediatric orthopedic experts have noted that 6 to 12 weeks of immobilization may be required for successful closed treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/15,17,23\">",
"     15,17,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Weekly orthopedic evaluation is appropriate for children with nondisplaced medial condylar fractures.",
"   </p>",
"   <p>",
"    Children who have received operative care (closed reduction with percutaneous pinning or open reduction with internal fixation) should be admitted for 24 to 48 hour observation of neurovascular status and soft tissue compartments. Once discharged, these patients are followed closely and may require weekly orthopedic evaluation with radiographs to determine the optimal timing for subsequent hardware removal. Also, range of motion exercises",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    physical therapy are recommended for these injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonunion is a common complication of lateral condylar fractures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76915 \" href=\"UTD.htm?15/8/15488\">",
"     image 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/24\">",
"     24",
"    </a>",
"    ]. A nonunion may lead to progressive displacement and proximal migration of the fragment. These events increase valgus deformity and may result in an ulnar nerve palsy that occurs many years after the injury [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/13,16\">",
"     13,16",
"    </a>",
"    ]. Once recognized, prompt surgical treatment of a nonunion is suggested. Before 12 weeks post-injury, anatomical reduction and percutaneous pinning can be used to fix a minimally displaced nonunion with good results [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/19,25\">",
"     19,25",
"    </a>",
"    ]. After 12 weeks post-injury, attempted reduction of a displacing nonunion is not recommended because of the risk for avascular necrosis. An open approach with bone grafting and internal fixation may be required at this stage [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/17,26\">",
"     17,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another complication of lateral condylar fractures is a \"fishtail deformity\" (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66848 \" href=\"UTD.htm?17/6/17504\">",
"     image 6",
"    </a>",
"    ). This term describes the inverted U or V shape resulting from the continued growth of the medial and lateral portions of the physis after premature closure of the central portion. It has been attributed to incomplete reduction and avascular necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/27\">",
"     27",
"    </a>",
"    ]. Because the distal humerus contributes little to the overall longitudinal growth of the humerus, length discrepancy is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/13\">",
"     13",
"    </a>",
"    ]. Although this deformity is generally well tolerated in children, future deformity could be minimized by surgical arrest of the remainder of the physis with little to no functional length discrepancy expected [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other complications of lateral condylar fractures include cubitus valgus or varus deformity (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50518 \" href=\"UTD.htm?30/32/31233\">",
"     image 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef63539 \" href=\"UTD.htm?17/52/18255\">",
"     figure 8",
"    </a>",
"    ), ulnar nerve palsy, and formation of lateral spurs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potential complications of medial condylar fractures include nonunion, physeal injury, avascular necrosis, cubitus varus or valgus deformity, ulnar nerve palsy, and loss of elbow motion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/3,5\">",
"     3,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis for long-term outcome and function following condylar elbow fractures is good if the fracture is diagnosed and treated in a timely manner. However, if missed, lateral or medial condylar fractures may result in nonunion and elbow deformity (cubitus valgus or varus), stiffness, or delayed ulnar nerve palsy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50518 \" href=\"UTD.htm?30/32/31233\">",
"     image 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef63539 \" href=\"UTD.htm?17/52/18255\">",
"     figure 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19175/abstract/28-31\">",
"     28-31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=see_link\">",
"       \"Patient information: Cast and splint care (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/35/20018?source=see_link\">",
"       \"Patient information: Elbow fracture in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=see_link\">",
"       \"Patient information: Cast and splint care (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lateral condylar elbow fractures are the second most common elbow fractures in children. Medial condylar elbow fractures are rare (&lt;1 percent of elbow fractures). Early recognition and proper management of these fractures is essential to avoid elbow deformity and functional impairment caused by nonunion. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16\">",
"     'Complications'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fall on an outstretched hand is a typical mechanism of injury for both medial and lateral condylar elbow fractures (",
"      <a class=\"graphic graphic_figure graphicRef53336 \" href=\"UTD.htm?36/46/37605\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef65109 \" href=\"UTD.htm?22/59/23479\">",
"       figure 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The child with a medial or lateral condylar elbow fracture has elbow pain and swelling over the medial or lateral elbow with limited range of motion. Neurovascular compromise is unusual. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Physical findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial treatment consists of pain management, application of a splint for comfort, elevation of the arm above the level of the heart, and radiographic evaluation. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Initial treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Condylar elbow fractures typically require four views (AP, lateral, and obliques) to be fully characterized. Comparison views with the unaffected elbow may be helpful in children with subtle fractures. Condylar elbow fractures in young children (&lt;5 years of age) often require magnetic resonance imaging or arthrography to differentiate lateral condylar from transphyseal fractures or medial condylar from medial epicondylar fractures. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Radiographic findings'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19607?source=see_link&amp;anchor=H8#H8\">",
"       \"Elbow anatomy and radiographic diagnosis of elbow fracture in children\", section on 'Plain radiographic views'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Classification of condylar elbow fractures based on the amount of radiographic displacement guides further care, including the need for orthopedic consultation at the time of the emergency department visit and operative care (",
"      <a class=\"graphic graphic_figure graphicRef52534 \" href=\"UTD.htm?35/10/36004\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Lateral condylar fracture'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Medial condylar fracture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prompt orthopedic consultation should be obtained in children with condylar elbow fractures that have &gt;2 mm of displacement on radiograph, open fractures, or fractures with neurovascular compromise (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60788 \" href=\"UTD.htm?39/23/40304\">",
"       image 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81394 \" href=\"UTD.htm?23/29/24031\">",
"       image 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Orthopedic consultation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Definitive care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Displaced lateral condylar fractures and most medial condylar fractures require open reduction and internal fixation. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Definitive care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/1\">",
"      Della-Giustina K, Della-Giustina DA. Emergency department evaluation and treatment of pediatric orthopedic injuries. Emerg Med Clin North Am 1999; 17:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/2\">",
"      Carson S, Woolridge DP, Colletti J, Kilgore K. Pediatric upper extremity injuries. Pediatr Clin North Am 2006; 53:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/3\">",
"      Gogola GR. Pediatric humeral condyle fractures. Hand Clin 2006; 22:77.",
"     </a>",
"    </li>",
"    <li>",
"     Bachman D, Santora S. Orthopedic trauma. In: Textbook of Pediatric Emergency Medicine, Fleisher GR, Ludwig S.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1538.",
"    </li>",
"    <li>",
"     Beaty JH, Kasser JR. The elbow: Physeal fractures, apophyseal injuries of the distal humerus, avascular necrosis of the trochlea, and T-condylar fractures. In: Rockwood and Wilkins' Fractures in Children, 5th, Beaty JH, Kasser JR.  (Eds), Lippincott, Williams, &amp; Wilkins, Philadelphia 2001. p.625.",
"    </li>",
"    <li>",
"     Green NE. Fractures and dislocations about the elbow. In: Skeletal Trauma in Children, 3rd, Green NE, Swiontkowski MF.  (Eds), WB Saunders, Philadelphia 2003. p.257.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/7\">",
"      Goodwin RC, Kuivila TE. Pediatric elbow and forearm fractures requiring surgical treatment. Hand Clin 2002; 18:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/8\">",
"      Baratz M, Micucci C, Sangimino M. Pediatric supracondylar humerus fractures. Hand Clin 2006; 22:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/9\">",
"      Lins RE, Simovitch RW, Waters PM. Pediatric elbow trauma. Orthop Clin North Am 1999; 30:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/10\">",
"      Jakob R, Fowles JV, Rang M, Kassab MT. Observations concerning fractures of the lateral humeral condyle in children. J Bone Joint Surg Br 1975; 57:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/11\">",
"      Mirsky EC, Karas EH, Weiner LS. Lateral condyle fractures in children: evaluation of classification and treatment. J Orthop Trauma 1997; 11:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/12\">",
"      Shrader MW. Pediatric supracondylar fractures and pediatric physeal elbow fractures. Orthop Clin North Am 2008; 39:163.",
"     </a>",
"    </li>",
"    <li>",
"     Price C, Phillips J, Devito D. Management of fractures. In: Lovell &amp; Winter's Pediatric Orthopaedics, Morrissy, Weinstein SL.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2001. p.1319.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/14\">",
"      MILCH H. FRACTURES AND FRACTURE DISLOCATIONS OF THE HUMERAL CONDYLES. J Trauma 1964; 4:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/15\">",
"      Bast SC, Hoffer MM, Aval S. Nonoperative treatment for minimally and nondisplaced lateral humeral condyle fractures in children. J Pediatr Orthop 1998; 18:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/16\">",
"      Flynn JC. Nonunion of slightly displaced fractures of the lateral humeral condyle in children: an update. J Pediatr Orthop 1989; 9:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/17\">",
"      Flynn JC, Richards JF Jr, Saltzman RI. Prevention and treatment of non-union of slightly displaced fractures of the lateral humeral condyle in children. An end-result study. J Bone Joint Surg Am 1975; 57:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/18\">",
"      Horn BD, Herman MJ, Crisci K, et al. Fractures of the lateral humeral condyle: role of the cartilage hinge in fracture stability. J Pediatr Orthop 2002; 22:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/19\">",
"      Papandrea R, Waters PM. Posttraumatic reconstruction of the elbow in the pediatric patient. Clin Orthop Relat Res 2000; :115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/20\">",
"      Woods GW, Tullos HS. Elbow instability and medial epicondyle fractures. Am J Sports Med 1977; 5:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/21\">",
"      Mintzer CM, Waters PM, Brown DJ, Kasser JR. Percutaneous pinning in the treatment of displaced lateral condyle fractures. J Pediatr Orthop 1994; 14:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/22\">",
"      Badelon O, Bensahel H, Mazda K, Vie P. Lateral humeral condylar fractures in children: a report of 47 cases. J Pediatr Orthop 1988; 8:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/23\">",
"      Flynn JC, Richards JF Jr. Non-union of minimally displaced fractures of the lateral condyle of the humerus in children. J Bone Joint Surg Am 1971; 53:1096.",
"     </a>",
"    </li>",
"    <li>",
"     Canale ST. Fractures and dislocations. In: Operative Pediatric Orthopaedics, 2nd, Canale ST, Beaty JH.  (Eds), Mosby, St. Louis 1995. p.913.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/25\">",
"      Roye DP Jr, Bini SA, Infosino A. Late surgical treatment of lateral condylar fractures in children. J Pediatr Orthop 1991; 11:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/26\">",
"      Masada K, Kawai H, Kawabata H, et al. Osteosynthesis for old, established non-union of the lateral condyle of the humerus. J Bone Joint Surg Am 1990; 72:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/27\">",
"      Nwakama AC, Peterson HA, Shaughnessy WJ. Fishtail deformity following fracture of the distal humerus in children: historical review, case presentations, discussion of etiology, and thoughts on treatment. J Pediatr Orthop B 2000; 9:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/28\">",
"      Ippolito E, Tudisco C, Farsetti P, Caterini R. Fracture of the humeral condyles in children: 49 cases evaluated after 18-45 years. Acta Orthop Scand 1996; 67:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/29\">",
"      El Ghawabi, MH. Fracture of the medial condyle of the humerus. J Bone Joint Surg 1975; 57:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/30\">",
"      Gay, JR, Love, JG. Diagnosis and treatment of tardy paralysis of the ulnar nerve. J Bone Joint Surg 1947; 29:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19175/abstract/31\">",
"      Leet AI, Young C, Hoffer MM. Medial condyle fractures of the humerus in children. J Pediatr Orthop 2002; 22:2.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6541 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-1.234.2.38-35693F307E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19175=[""].join("\n");
var outline_f18_46_19175=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PERTINENT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PHYSICAL FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lateral condylar fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Medial condylar fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Analgesia and immobilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Orthopedic consultation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Definitive care",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Lateral condylar fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Medial condylar fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6541\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6541|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/61/31697\" title=\"diagnostic image 1\">",
"      Stage I lateral condyle fracture 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/25/10644\" title=\"diagnostic image 2\">",
"      Stage I lateral condyle fracture 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/23/40304\" title=\"diagnostic image 3\">",
"      Stage II lateral condyle fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/29/24031\" title=\"diagnostic image 4\">",
"      Stage III lateral condyle fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/8/15488\" title=\"diagnostic image 5\">",
"      Nonunion lateral condyle fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/6/17504\" title=\"diagnostic image 6\">",
"      Fishtail deformity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/32/31233\" title=\"diagnostic image 7\">",
"      Cubitus valgus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6541|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/25/30111\" title=\"figure 1\">",
"      Supracondylar anatomy child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/10/36004\" title=\"figure 2\">",
"      Lateral condyle fracture anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/52/23363\" title=\"figure 3\">",
"      Medial condyle fracture anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/46/37605\" title=\"figure 4\">",
"      Mechanism for lateral condyle elbow fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/59/23479\" title=\"figure 5\">",
"      Mechanism for medial condyle elbow fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/18/26918\" title=\"figure 6\">",
"      Growth plate anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/55/21361\" title=\"figure 7\">",
"      Salter-Harris classification system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/52/18255\" title=\"figure 8\">",
"      Cubitus varus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/9/19607?source=related_link\">",
"      Elbow anatomy and radiographic diagnosis of elbow fracture in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22663?source=related_link\">",
"      Epicondylar and transphyseal elbow fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25961?source=related_link\">",
"      Evaluation and management of supracondylar fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20104?source=related_link\">",
"      General principles of fracture management: Fracture patterns and description in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/21/25937?source=related_link\">",
"      Patient information: Cast and splint care (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/51/11058?source=related_link\">",
"      Patient information: Cast and splint care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/35/20018?source=related_link\">",
"      Patient information: Elbow fracture in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_46_19176="Adenoid cystic carcinoma Light";
var content_f18_46_19176=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F67445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F67445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 574px\">",
"   <div class=\"ttl\">",
"    Adenoid cystic carcinoma of salivary gland",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 554px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph of an adenoid cystic carcinoma; the cribriform spaces filled with blue mucous or pink hyalin material (left panel, black arrow) are the most characteristic feature of this tumor. These tumors have a tendency to invade bone (right panel, black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of G Kenneth Haines, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19176=[""].join("\n");
var outline_f18_46_19176=null;
var title_f18_46_19177="Overview of the treatment of newly diagnosed, non-metastatic breast cancer";
var content_f18_46_19177=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Alphonse Taghian, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Moataz N El-Ghamry, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Sofia D Merajver, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19177/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/46/19177/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Globally, breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. In the United States, breast cancer is the most commonly diagnosed cancer and the second most common cause of cancer death in women. In addition, breast cancer is the leading cause of death in women ages 40 to 49 years.",
"   </p>",
"   <p>",
"    Breast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology, which has been associated with a reduction in breast cancer mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will provide an overview of the initial treatment to breast cancer and posttreatment surveillance. The epidemiology, clinical manifestations, diagnosis, staging of breast cancer, and specific discussions of the multimodality treatments for early breast cancer and the approach to metastatic disease are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/49/10009?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of newly diagnosed breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=see_link\">",
"     \"Systemic treatment for metastatic breast cancer: General principles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=see_link\">",
"     \"Metastatic breast cancer: Local treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because ductal carcinoma in situ (DCIS) and invasive breast cancer are managed differently, we will restrict discussion in this topic to invasive breast cancer. A discussion on DCIS is covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/33/6680?source=see_link\">",
"     \"Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37561?source=see_link\">",
"     \"Ductal carcinoma in situ: Treatment and prognosis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3101248\">",
"    <span class=\"h1\">",
"     PATIENT STRATIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of patients with newly diagnosed breast cancer in the United States and developed countries have no evidence of metastatic disease. For these patients, the treatment approach depends on the stage at presentation. For treatment purposes, breast cancer is characterized using the Tumor, Node, Metastases system (TNM) as (",
"    <a class=\"graphic graphic_table graphicRef65393 \" href=\"UTD.htm?29/14/29920\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Early stage",
"      </strong>",
"      &mdash; This includes patients with clinical stage I, IIA, or IIB disease and a subset of patients with clinical stage IIIA disease with a tumor &gt;5 cm but no clinical evidence of node involvement (T3N0). &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Locally advanced",
"      </strong>",
"      &mdash;This includes a subset of patients with clinical stage IIIA disease, defined as a T0 to T3 breast cancers with clinically detected, fixed, or matted axillary lymph nodes (N2 disease), and those patients presenting with disease extending to the chest all or skin (T4) regardless of nodal status (N0 to N2).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately five percent of patients will have simultaneous metastatic disease identified at the initial presentation (de novo stage IV breast cancer). The treatment approach to these patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=see_link\">",
"     \"Systemic treatment for metastatic breast cancer: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H528513260\">",
"    <span class=\"h1\">",
"     EARLY STAGE BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, patients with early stage breast cancer undergo primary surgery (lumpectomy or mastectomy) to the breast and regional nodes with or without radiation therapy (RT). Following definitive local treatment, adjuvant systemic therapy may be offered based on primary tumor characteristics, such as tumor size, grade, number of involved lymph nodes, and the status of estrogen (ER), progesterone (PR) receptors, and expression of the human epidermal growth factor 2 (HER2) receptor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H376306286\">",
"    <span class=\"h2\">",
"     Breast conserving therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast conserving therapy (BCT) is comprised of breast conserving surgery (BCS, ie, lumpectomy) plus radiation therapy (RT). The goals of BCT are to provide the survival equivalent of mastectomy, a cosmetically acceptable breast, and a low rate of recurrence in the treated breast. BCT allows patients with invasive breast cancer to preserve their breast without sacrificing oncologic outcome. Successful BCT requires complete surgical removal of the tumor (with negative surgical margins) followed by moderate-dose RT to eradicate any residual disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link\">",
"     \"Breast conserving therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Criteria that preclude breast conserving therapy include (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link&amp;anchor=H7#H7\">",
"     \"Breast conserving therapy\", section on 'Patient selection for BCT'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Multicentric disease",
"     </li>",
"     <li>",
"      Large tumor size in relation to breast",
"     </li>",
"     <li>",
"      Presence of diffuse malignant-appearing calcifications on imaging (ie, mammogram or MRI)",
"     </li>",
"     <li>",
"      Prior history of chest wall RT",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"     <li>",
"      Persistently positive margins despite attempts at re-excision",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients who desire breast conserving therapy but are not candidates at the time of presentation, an alternative approach is the use of neoadjuvant therapy, which may allow for breast conserving surgery without compromising survival outcomes. (See",
"    <a class=\"local\" href=\"#H528514040\">",
"     'Neoadjuvant systemic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29914106\">",
"    <span class=\"h2\">",
"     Mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mastectomy is indicated for patients who are not candidates for breast conserving therapy and those who prefer mastectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=see_link&amp;anchor=H1378592045#H1378592045\">",
"     \"Mastectomy\", section on 'Selection criteria for mastectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29914113\">",
"    <span class=\"h3\">",
"     Role of RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postmastectomy RT is indicated for patients at high risk for local recurrence, such as those with cancer involving the deep margins and pathologically involved axillary lymph nodes. If the likelihood of postmastectomy RT is high preoperatively, this may affect the choice of mastectomy type, the choice of the reconstructive approach, and optimal timing of the breast reconstruction (immediate versus delayed). Thus,",
"    <strong>",
"     preoperative",
"    </strong>",
"    coordination of care assures the best outcome. In many centers, this is accomplished by multi-disciplinary breast clinics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=see_link\">",
"     \"Postmastectomy chest wall irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12417951\">",
"    <span class=\"h2\">",
"     Evaluation of the axillary nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk for metastases to the axillary nodes is related to tumor size and location, histologic grade, and the presence of lymphatic invasion within the primary tumor. Although internal mammary or supraclavicular nodes may be involved at the initial presentation, they rarely occur in the absence of axillary node involvement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of the regional lymph nodes in breast cancer\", section on 'Internal mammary lymph nodes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of the regional lymph nodes in breast cancer\", section on 'Supraclavicular lymph nodes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation of the regional nodes depends on whether axillary involvement is suspected prior to surgery:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients presenting with a clinically suspicious axillary lymph nodes, a preoperative work up including ultrasound plus fine needle aspiration (FNA) or core biopsy can help to determine the best surgical approach.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with a positive biopsy, an axillary node dissection should be performed at the time of breast surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=see_link\">",
"       \"Technique of axillary lymph node dissection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients presenting with a negative biopsy, no further work-up is required prior to surgery. These patients should undergo a sentinel lymph node biopsy at the time of surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=see_link\">",
"       \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20296?source=see_link\">",
"       \"Sentinel lymph node biopsy in breast cancer: Techniques\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a clinically negative axillary examination should undergo a sentinel lymph node biopsy (SLNB) at the time of surgery. Further evaluation of the regional nodes depends on the findings at SLNB.",
"     </li>",
"     <li>",
"      Patients who have less than three pathologically involved sentinel nodes may not require a complete axillary node dissection [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/2\">",
"       2",
"      </a>",
"      ]. However, whether or not patients with three or more pathologically involved sentinel nodes should undergo an axillary node dissection is best determined on an individualized basis, taking into account all other tumor risk factors and the patient&rsquo;s performance status and comorbidities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=see_link&amp;anchor=H5456194#H5456194\">",
"       \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\", section on 'When should completion axillary dissection be performed?'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12418377\">",
"    <span class=\"h2\">",
"     Adjuvant therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic therapy refers to the medical treatment of breast cancer using endocrine therapy, chemotherapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biologic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link\">",
"     \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=see_link\">",
"     \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link\">",
"     \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tumor characteristics predict which patients are likely to benefit from specific types of therapy. For example, hormone receptor positive patients benefit from the use of endocrine therapy. In addition, patients with human epidermal growth factor 2 (HER2) positive cancers benefit from treatment using HER2-directed treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/28/43465?source=see_link\">",
"     \"Measurement of prognostic factors in breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with early stage breast cancer, treatment is based on tumor characteristics, patient status, and patient preferences:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with hormone receptor-positive breast cancer should receive endocrine therapy. Whether they also should receive adjuvant chemotherapy depends on patient and tumor characteristics. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link\">",
"       \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link&amp;anchor=H115555550#H115555550\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\", section on 'Indications for treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We offer chemotherapy to patients with early stage hormone receptor-positive cancers that have high-risk characteristics, such as high grade tumor, large tumor size (&ge;2 cm), pathologically involved lymph nodes,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      high 21-gene recurrence score (&ge;31).",
"     </li>",
"     <li>",
"      In the absence of high-risk features, we prefer not to administer chemotherapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with",
"      <span class=\"nowrap\">",
"       ER/PR",
"      </span>",
"      and HER2-negative disease (triple-negative breast cancer), we prefer to administer adjuvant chemotherapy if the tumor size &ge;0.5 cm. Because these patients are not candidates for endocrine therapy or treatment with HER2-directed agents, chemotherapy is their only option for adjuvant treatment, following or before radiotherapy. Patients with a triple-negative breast cancer &lt;0.5 cm in size may forgo adjuvant chemotherapy in most cases, due to minimal, if any, survival advantage. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=see_link\">",
"       \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with HER2-positive breast cancer with a tumor size &gt;1 cm should receive a combination of chemotherapy plus HER2-directed therapy. The management of small (&le;1 cm) HER2-positive breast cancers is controversial. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=see_link&amp;anchor=H3#H3\">",
"       \"Adjuvant medical therapy for HER2-positive breast cancer\", section on 'Indications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Following chemotherapy, patients with ER-positive disease should also receive adjuvant endocrine therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=see_link\">",
"       \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link&amp;anchor=H659778#H659778\">",
"       \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\", section on 'Patients with HER2-positive tumors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H528513711\">",
"    <span class=\"h1\">",
"     LOCALLY ADVANCED BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Locally advanced breast cancer is best managed with multimodality therapy employing systemic and locoregional therapy. (See",
"    <a class=\"local\" href=\"#H3101248\">",
"     'Patient stratification'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H528514040\">",
"    <span class=\"h2\">",
"     Neoadjuvant systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with locally advanced breast cancer should receive neoadjuvant systemic therapy. The goal of treatment is to induce a tumor response before surgery and enable breast conservation.",
"   </p>",
"   <p>",
"    Neoadjuvant therapy results in long-term distant disease-free survival and overall survival comparable to that achieved with primary surgery followed by adjuvant systemic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H11989615#H11989615\">",
"     \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Patient selection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Our approach to the selection of treatment in the neoadjuvant setting is outlined below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For most patients with hormone receptor-positive disease, we recommend chemotherapy in the neoadjuvant setting rather than endocrine therapy. Chemotherapy is associated with higher response rates in a shorter time period. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H11989615#H11989615\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Patient selection'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with HER2-positive breast cancer, a HER2-directed agent (ie,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      ) should be added to the chemotherapy regimen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H541773077#H541773077\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'HER2-directed therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We restrict endocrine therapy in the neoadjuvant setting to the treatment of postmenopausal patients with hormone receptor-positive disease who are not surgical candidates (regardless of tumor size) with a relative or absolute contraindication to chemotherapy (ie, significant medical comorbidities, advanced age, or poor performance status). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H19285752#H19285752\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Endocrine therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H11989615#H11989615\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Patient selection'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878713\">",
"    <span class=\"h3\">",
"     Surgical approach after neoadjuvant treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients should undergo surgery following neoadjuvant systemic therapy, even if they have a complete clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiological response. In addition, patients who experience progression while on neoadjuvant systemic therapy should proceed with surgery, rather than switch in chemotherapy regimen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H544206548#H544206548\">",
"     \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Definitive surgical treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878754\">",
"    <span class=\"h4\">",
"     Primary tumor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice between breast conservation and mastectomy after neoadjuvant treatment is dependent on the treatment response and patient characteristics (eg, breast size in relation to residual tumor size). Similar criteria used in the treatment of early stage breast cancer are applied. However, patients who presented with a large (ie, T4) breast lesion should undergo a mastectomy following neoadjuvant treatment. (See",
"    <a class=\"local\" href=\"#H376306286\">",
"     'Breast conserving therapy'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H29914106\">",
"     'Mastectomy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878761\">",
"    <span class=\"h4\">",
"     Regional nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients require a surgical evaluation of the regional nodes following neoadjuvant treatment. (See",
"    <a class=\"local\" href=\"#H12417951\">",
"     'Evaluation of the axillary nodes'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H1192519#H1192519\">",
"     \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Nodal evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878798\">",
"    <span class=\"h2\">",
"     Primary surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although some patients may be candidates for primary surgery at presentation, patients with locally advanced disease have an extremely high risk of local recurrence and distant metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/3\">",
"     3",
"    </a>",
"    ]. As a result, we prefer to treat patients with locally advanced breast cancer with neoadjuvant systemic therapy first.",
"   </p>",
"   <p>",
"    For patients who proceed with primary surgery, postoperative RT and adjuvant treatment should be administered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/55/42873?source=see_link\">",
"     \"Radiation techniques for locally advanced breast cancer\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H105748848\">",
"     'Adjuvant therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H105748848\">",
"    <span class=\"h2\">",
"     Adjuvant therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of postoperative (adjuvant) systemic therapy is guided by the patient&rsquo;s clinical status and tumor characteristics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who did not receive neoadjuvant systemic therapy should receive adjuvant treatment. The use of chemotherapy, biologic therapy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endocrine therapy is guided by the same principles used to determine treatment for early stage breast cancer. (See",
"      <a class=\"local\" href=\"#H12418377\">",
"       'Adjuvant therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who received the full course of planned neoadjuvant chemotherapy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H544206590#H544206590\">",
"       \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Chemotherapy'",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with hormone receptor-positive breast cancer should receive endocrine therapy to reduce the risk of breast cancer recurrence and breast cancer-related mortality. There is no evidence that the addition of further chemotherapy in the form of adjuvant treatment improves overall survival. The selection of endocrine therapy is made according to menopausal status. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H544206604#H544206604\">",
"       \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Endocrine therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with hormone receptor-negative breast cancer would typically not receive further chemotherapy in the adjuvant setting, as there is no evidence that the addition of adjuvant chemotherapy improves overall survival. These patients should begin posttreatment surveillance. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=see_link&amp;anchor=H346411030#H346411030\">",
"       \"Approach to the long-term survivor of breast cancer\", section on 'Guidelines for posttreatment follow-up'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In some exceptional cases where the tumor progressed during neoadjuvant therapy or if the complete neoadjuvant therapy could not be delivered at the normal levels of intensity, adjuvant chemotherapy should be discussed and considered.",
"     </li>",
"     <li>",
"      Patients with HER2-positive breast cancer should receive one year of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      following completion of surgery without the addition of further chemotherapy. This recommendation is based on studies of adjuvant chemotherapy with or without trastuzumab that demonstrated the addition of one year of trastuzumab significantly improves disease-free survival and overall survival. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H544206597#H544206597\">",
"       \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'HER2-directed treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients treated with neoadjuvant endocrine therapy who undergo surgery should continue endocrine therapy in the adjuvant setting. Whether or not to administer adjuvant chemotherapy should be individualized. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H11989101#H11989101\">",
"     \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Objectives'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878859\">",
"    <span class=\"h1\">",
"     SPECIAL CONSIDERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1672187603\">",
"    <span class=\"h2\">",
"     Fertility preservation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physicians should discuss with patients the risk of infertility and possible interventions to preserve fertility prior to initiating potentially gonadotoxic therapy. This discussion should occur soon after diagnosis since some interventions to preserve fertility take time and could delay the start of treatment. This is consistent with guidance from the American Society of Clinical Oncology [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/4\">",
"     4",
"    </a>",
"    ]. The topic of fertility preservation is covered in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=see_link\">",
"     \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878830\">",
"    <span class=\"h2\">",
"     Older women",
"    </span>",
"    &nbsp;&mdash;&nbsp;For some patients with ER-positive breast cancer, in whom surgery is not an option or life expectancy is limited, primary hormonal treatment with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    or an aromatase inhibitor without surgery or RT can be used [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/5\">",
"     5",
"    </a>",
"    ]. We prefer to individualize treatment based on the presence of medical comorbidities, patient, and physician preference. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13226?source=see_link&amp;anchor=H20722981#H20722981\">",
"     \"General principles on the treatment of early stage and locally advanced breast cancer in older women\", section on 'Surgery versus primary endocrine therapy in women with hormone receptor-positive disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878874\">",
"    <span class=\"h2\">",
"     Male breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The topic of male breast cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26186?source=see_link\">",
"     \"Breast cancer in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878894\">",
"    <span class=\"h2\">",
"     Breast cancer in pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of breast cancer in pregnancy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2602?source=see_link\">",
"     \"Breast cancer during pregnancy and lactation: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12417845\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of breast cancer recurrences occur within the first five years of diagnosis, particularly with hormone receptor-negative disease. However, some recurrences occur much later. In one study of patients with stage I, II, or III breast cancer who were without evidence of disease five years out from the original diagnosis, the recurrence risks in the subsequent five and ten years were still 11 and 19 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8202?source=see_link&amp;anchor=H2#H2\">",
"     \"Patterns of relapse and long-term complications of therapy in breast cancer survivors\", section on 'Relapse patterns'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with early stage breast cancer have a better prognosis than those patients diagnosed with locally advanced disease. According to TNM stage, five-year relative survival rates by stage at for patients presenting with stage I, IIA, IIB, IIIA, IIIB, and IV disease were 95, 85, 70, 52, 48, and 18, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/7\">",
"     7",
"    </a>",
"    ]. Both younger (age &lsaquo;35 years) and older age (age &ge;65 years) at diagnosis are associated with a worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/28/43465?source=see_link\">",
"     \"Measurement of prognostic factors in breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there is some controversy regarding the prognosis of patients who present with synchronous breast cancer (ie, bilateral breast cancer diagnosed simultaneously), a recent study suggests their prognosis is no different from patients presenting with unilateral breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of multifocal (ie, invasive tumors identified within the same breast quadrant) or multicentric (ie, invasive tumors identified in separate breast quadrants) tumors on prognosis is controversial with some evidence that they are associated with a poor prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/11\">",
"     11",
"    </a>",
"    ] and other data suggesting they do not impact prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/12\">",
"     12",
"    </a>",
"    ]. Currently, the TNM staging system does not assign independent value to multifocality or multicentricity and uses the diameter of the largest lesion to assign T stage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29914274\">",
"    <span class=\"h2\">",
"     Resumption of menses",
"    </span>",
"    &nbsp;&mdash;&nbsp;For premenopausal patients who received adjuvant chemotherapy, chemotherapy induced-amenorrhea and lack of resumption of menstrual cycles after chemotherapy is associated with improved survival, after controlling for standard prognostic variables, particularly for hormone receptor-positive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19177/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12418853\">",
"    <span class=\"h1\">",
"     POSTTREATMENT SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer survivors who have completed treatment for breast cancer should undergo regular follow-up. Annual mammography should also be performed in patients who underwent breast conserving therapy. The routine use of breast MRI or whole breast ultrasound is not recommended for breast cancer survivors because of a lack of evidence to inform their role in this population. In addition, laboratory tests and whole body imaging in asymptomatic cancer survivors is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8202?source=see_link&amp;anchor=H6#H6\">",
"     \"Patterns of relapse and long-term complications of therapy in breast cancer survivors\", section on 'Long-term adverse effects of primary therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=see_link&amp;anchor=H346411030#H346411030\">",
"     \"Approach to the long-term survivor of breast cancer\", section on 'Guidelines for posttreatment follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/19/2357?source=see_link\">",
"       \"Patient information: Breast cancer (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/8/8321?source=see_link\">",
"       \"Patient information: Choosing treatment for early-stage breast cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/56/12167?source=see_link\">",
"       \"Patient information: Breast cancer guide to diagnosis and treatment (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/6/44134?source=see_link\">",
"       \"Patient information: Factors that modify breast cancer risk in women (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/52/26437?source=see_link\">",
"       \"Patient information: Early stage breast cancer treatment in postmenopausal women (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/2/39970?source=see_link\">",
"       \"Patient information: Early stage breast cancer treatment in premenopausal women (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?26/44/27335?source=see_link\">",
"       \"Patient information: Surgical procedures for breast cancer &mdash; Mastectomy and breast conserving therapy (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/53/25426?source=see_link\">",
"       \"Patient information: Adjuvant medical therapy for HER2-positive breast cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/47/5875?source=see_link\">",
"       \"Patient information: Locally advanced and inflammatory breast cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8580118\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8995612\">",
"    <span class=\"h2\">",
"     Patient stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a new diagnosis of breast cancer can be stratified by their extent of disease (see",
"    <a class=\"local\" href=\"#H3101248\">",
"     'Patient stratification'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with clinical stage I, IIA, or IIB disease and a subset of patients with clinical stage IIIA disease with a tumor &gt;5 cm but no clinical evidence of node involvement (T3N0) are classified as having",
"      <strong>",
"       early stage breast cancer",
"      </strong>",
"      . &nbsp;",
"     </li>",
"     <li>",
"      Patients with T0 to T3 breast cancers with clinically detected, fixed, or matted axillary lymph nodes (N2 disease), and those patients presenting with disease extending to the chest all or skin (T4) regardless of nodal status (N0 to N2) are classified as having",
"      <strong>",
"       locally advanced breast cancer",
"      </strong>",
"      .",
"     </li>",
"     <li>",
"      Approximately five percent of patients will present with distant metastases at diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878009\">",
"    <span class=\"h2\">",
"     Early stage breast cancer",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The surgical approach to the primary tumor depends on the size of the tumor, whether or not multifocal disease is present, and the size of the breast. The options include breast conserving therapy (breast conserving surgery plus radiation therapy [RT]) or mastectomy (with or without RT). Both approaches result in equivalent cancer-specific outcomes. (See",
"      <a class=\"local\" href=\"#H528513260\">",
"       'Early stage breast cancer'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link\">",
"       \"Breast conserving therapy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=see_link\">",
"       \"Mastectomy\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      The risk for metastatic disease in the regional nodes is related to tumor size, histologic grade, and the presence of lymphatic invasion within the primary tumor. Although internal mammary or supraclavicular nodes may also be involved at the initial presentation, they rarely occur in the absence of axillary node involvement. The surgical approach to the regional nodes depends on the clinical status of the axilla (see",
"      <a class=\"local\" href=\"#H12417951\">",
"       'Evaluation of the axillary nodes'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients presenting with a clinically suspicious axillary, a preoperative work up including ultrasound plus lymph node biopsy can help to determine the best surgical approach. If the lymph node biopsy is positive, an axillary node dissection should be performed. If the lymph node biopsy is negative, a sentinel lymph node biopsy (SLNB) at the time of surgery should be performed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=see_link&amp;anchor=H365147057#H365147057\">",
"       \"Management of the regional lymph nodes in breast cancer\", section on 'Axillary ultrasound'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=see_link&amp;anchor=H11#H11\">",
"       \"Management of the regional lymph nodes in breast cancer\", section on 'Axillary dissection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=see_link&amp;anchor=H9#H9\">",
"       \"Management of the regional lymph nodes in breast cancer\", section on 'Sentinel lymph node biopsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who present with a clinically negative axilla do not require a preoperative work-up. These patients should undergo a SLNB at the time of definitive breast surgery. Patients who have &lt;3 pathologically involved sentinel nodes by SLNB might not require an axillary node dissection. Whether or not patients with &ge;3 pathologically involved sentinel nodes involved should undergo an axillary node dissection is best determined on an individualized basis taking into account all other tumor risk factors and the patient&rsquo;s performance status and comorbidities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=see_link\">",
"       \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tumor characteristics are used to select adjuvant treatment for patients with breast cancer. (See",
"      <a class=\"local\" href=\"#H12418377\">",
"       'Adjuvant therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with hormone receptor-positive breast cancer should receive adjuvant endocrine therapy. The role of adjuvant chemotherapy in these patients requires risk-stratified approach that takes into account patient and tumor characteristics to select patients who should receive adjuvant chemotherapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link\">",
"       \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link&amp;anchor=H115555550#H115555550\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\", section on 'Indications for treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with ER, PR, and HER2-negative disease (triple-negative breast cancer), we prefer to administer adjuvant chemotherapy if the tumor size &gt;0.5 cm. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=see_link\">",
"       \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with HER2-positive breast cancer &gt;1 cm in size should receive a combination of chemotherapy plus HER2-directed therapy. Following chemotherapy, patients with ER-positive disease should also receive adjuvant endocrine therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=see_link\">",
"       \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=see_link&amp;anchor=H659778#H659778\">",
"       \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\", section on 'Patients with HER2-positive tumors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435878509\">",
"    <span class=\"h2\">",
"     Locally advanced breast cancer",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with locally advanced, inoperable breast cancer should receive neoadjuvant systemic therapy rather than proceed with primary surgery. These patients are usually not candidates for breast conservation at their initial presentation. Neoadjuvant treatment improves the rate of breast conservation without compromising survival outcomes. (See",
"      <a class=\"local\" href=\"#H528514040\">",
"       'Neoadjuvant systemic therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For most patients, we recommend chemotherapy in the neoadjuvant setting rather than endocrine therapy. Chemotherapy is associated with higher response rates in a faster time frame. A HER2-directed agent (ie,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      ) should be added to the chemotherapy regimen for tumors that are HER2-positive. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H89686859#H89686859\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Eligibility for primary surgery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We restrict endocrine therapy in the neoadjuvant setting to the treatment of postmenopausal patients who are not surgical candidates at the time of presentation and have a relative or absolute contraindication to chemotherapy (ie, significant medical comorbidities, advanced age, or poor performance status). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H19285752#H19285752\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Endocrine therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H89686859#H89686859\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Eligibility for primary surgery'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following surgery (with or without neoadjuvant systemic therapy), all patients who undergo breast conserving surgery should undergo adjuvant RT to maximize locoregional control. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/55/42873?source=see_link&amp;anchor=H16#H16\">",
"       \"Radiation techniques for locally advanced breast cancer\", section on 'Radiation therapy techniques and doses for LABC'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some patients treated by a mastectomy should receive postmastectomy RT. The administration of adjuvant RT should be based upon the original pretreatment stage, regardless of the pathologic response to neoadjuvant therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=see_link\">",
"       \"Postmastectomy chest wall irradiation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link\">",
"       \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=see_link\">",
"       \"Role of radiation therapy in breast conservation therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The use of chemotherapy, biologic therapy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      endocrine therapy is guided by the same principles used to determine treatment for early stage breast cancer. (See",
"      <a class=\"local\" href=\"#H12418377\">",
"       'Adjuvant therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who received neoadjuvant chemotherapy:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with hormone receptor-positive breast cancer should receive adjuvant endocrine therapy. The selection of endocrine therapy is made according to menopausal status. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H544206604#H544206604\">",
"       \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'Endocrine therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with hormone receptor-negative breast cancer should not receive further treatment provided they completed the planned neoadjuvant chemotherapy regimen. These patients should begin posttreatment surveillance. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=see_link&amp;anchor=H346411030#H346411030\">",
"       \"Approach to the long-term survivor of breast cancer\", section on 'Guidelines for posttreatment follow-up'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with hormone receptor-negative breast cancer who did not complete planned neoadjuvant treatment prior to surgery are candidates for further chemotherapy in the postoperative (or adjuvant) setting.",
"     </li>",
"     <li>",
"      Patients with HER2-positive breast cancer should receive one year of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      following completion of surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=see_link&amp;anchor=H544206597#H544206597\">",
"       \"Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis\", section on 'HER2-directed treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients treated with neoadjuvant endocrine therapy who undergo surgery should continue endocrine therapy in the adjuvant setting. Whether or not to administer adjuvant chemotherapy should be individualized. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H19285752#H19285752\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Endocrine therapy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H89686859#H89686859\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Eligibility for primary surgery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For some patients with ER-positive breast cancer, in whom surgery is not an option or life expectancy is limited, primary hormonal treatment with either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      or an aromatase inhibitor without surgery can be used. (See",
"      <a class=\"local\" href=\"#H435878830\">",
"       'Older women'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13226?source=see_link&amp;anchor=H20722981#H20722981\">",
"       \"General principles on the treatment of early stage and locally advanced breast cancer in older women\", section on 'Surgery versus primary endocrine therapy in women with hormone receptor-positive disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/1\">",
"      Kesson EM, Allardice GM, George WD, et al. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 2012; 344:e2718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/2\">",
"      Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/3\">",
"      Haagensen CD, Stout AP. CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY. Ann Surg 1943; 118:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/4\">",
"      Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24:2917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/5\">",
"      Hamaker ME, Bastiaannet E, Evers D, et al. Omission of surgery in elderly patients with early stage breast cancer. Eur J Cancer 2013; 49:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/6\">",
"      Brewster AM, Hortobagyi GN, Broglio KR, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 2008; 100:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/7\">",
"      Newman LA. Epidemiology of locally advanced breast cancer. Semin Radiat Oncol 2009; 19:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/8\">",
"      Bastiaannet E, Liefers GJ, de Craen AJ, et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 2010; 124:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/9\">",
"      van de Water W, Markopoulos C, van de Velde CJ, et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012; 307:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/10\">",
"      Nichol AM, Yerushalmi R, Tyldesley S, et al. A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol 2011; 29:4763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/11\">",
"      Weissenbacher TM, Zschage M, Janni W, et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 2010; 122:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/12\">",
"      Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol 2012; 23:3063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19177/abstract/13\">",
"      Swain SM, Jeong JH, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010; 362:2053.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 737 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-820E8C5BBF-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19177=[""].join("\n");
var outline_f18_46_19177=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8580118\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3101248\">",
"      PATIENT STRATIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H528513260\">",
"      EARLY STAGE BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H376306286\">",
"      Breast conserving therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29914106\">",
"      Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29914113\">",
"      - Role of RT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12417951\">",
"      Evaluation of the axillary nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12418377\">",
"      Adjuvant therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H528513711\">",
"      LOCALLY ADVANCED BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H528514040\">",
"      Neoadjuvant systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H435878713\">",
"      - Surgical approach after neoadjuvant treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H435878754\">",
"      Primary tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H435878761\">",
"      Regional nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435878798\">",
"      Primary surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H105748848\">",
"      Adjuvant therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H435878859\">",
"      SPECIAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1672187603\">",
"      Fertility preservation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435878830\">",
"      Older women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435878874\">",
"      Male breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435878894\">",
"      Breast cancer in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12417845\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29914274\">",
"      Resumption of menses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12418853\">",
"      POSTTREATMENT SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8580118\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8995612\">",
"      Patient stratification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435878009\">",
"      Early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435878509\">",
"      Locally advanced breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/737\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/737|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/14/29920\" title=\"table 1\">",
"      TNM stage breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=related_link\">",
"      Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20106?source=related_link\">",
"      Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11384?source=related_link\">",
"      Adjuvant medical therapy for HER2-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=related_link\">",
"      Approach to the long-term survivor of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2602?source=related_link\">",
"      Breast cancer during pregnancy and lactation: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26186?source=related_link\">",
"      Breast cancer in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=related_link\">",
"      Breast conserving therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/33/6680?source=related_link\">",
"      Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/49/10009?source=related_link\">",
"      Clinical features, diagnosis, and staging of newly diagnosed breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37561?source=related_link\">",
"      Ductal carcinoma in situ: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=related_link\">",
"      Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=related_link\">",
"      Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13226?source=related_link\">",
"      General principles on the treatment of early stage and locally advanced breast cancer in older women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42825?source=related_link\">",
"      Management of the regional lymph nodes in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12586?source=related_link\">",
"      Mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/28/43465?source=related_link\">",
"      Measurement of prognostic factors in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=related_link\">",
"      Metastatic breast cancer: Local treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1529?source=related_link\">",
"      Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=related_link\">",
"      Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/53/25426?source=related_link\">",
"      Patient information: Adjuvant medical therapy for HER2-positive breast cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/19/2357?source=related_link\">",
"      Patient information: Breast cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/56/12167?source=related_link\">",
"      Patient information: Breast cancer guide to diagnosis and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/8/8321?source=related_link\">",
"      Patient information: Choosing treatment for early-stage breast cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/52/26437?source=related_link\">",
"      Patient information: Early stage breast cancer treatment in postmenopausal women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/2/39970?source=related_link\">",
"      Patient information: Early stage breast cancer treatment in premenopausal women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/6/44134?source=related_link\">",
"      Patient information: Factors that modify breast cancer risk in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/47/5875?source=related_link\">",
"      Patient information: Locally advanced and inflammatory breast cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/44/27335?source=related_link\">",
"      Patient information: Surgical procedures for breast cancer &mdash; Mastectomy and breast conserving therapy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8202?source=related_link\">",
"      Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=related_link\">",
"      Postmastectomy chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/55/42873?source=related_link\">",
"      Radiation techniques for locally advanced breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=related_link\">",
"      Role of radiation therapy in breast conservation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20296?source=related_link\">",
"      Sentinel lymph node biopsy in breast cancer: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=related_link\">",
"      Sentinel lymph node dissection for breast cancer: Indications and outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=related_link\">",
"      Systemic treatment for metastatic breast cancer: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=related_link\">",
"      Technique of axillary lymph node dissection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_46_19178="Postoperative fever";
var content_f18_46_19178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postoperative fever",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Harrison G Weed, MS, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Larry M Baddour, MD, FIDSA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Hilary Sanfey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/46/19178/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/46/19178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever above 38&ordm;C (100.4&ordm;F) is common in the first few days after major surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Most early postoperative fever is caused by the inflammatory stimulus of surgery and resolves spontaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. However, postoperative fever can be a manifestation of a serious complication.",
"   </p>",
"   <p>",
"    A thorough differential diagnosis of postoperative fever includes infectious and noninfectious conditions that occur following surgery. Fever may arise due to a surgical site infection (SSI), or from other hospital-related conditions, including nosocomial pneumonia, urinary tract infection, drug fever, and deep vein thrombosis (",
"    <a class=\"graphic graphic_table graphicRef69959 \" href=\"UTD.htm?39/14/40172\">",
"     table 1",
"    </a>",
"    ). In evaluating a postoperative patient with fever, it is important to consider a broad differential, and not to assume that fever is due to infection.",
"   </p>",
"   <p>",
"    Fever as a manifestation of infection may be reduced or absent in immunocompromised patients including those receiving glucocorticoids, cancer chemotherapy, post-transplant immunosuppression, and also in some patients who are elderly or have chronic renal failure.",
"   </p>",
"   <p>",
"    The evaluation of fever in immunocompromised patients is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42537?source=see_link\">",
"     \"Infectious causes of fever and rash in non-HIV immunocompromised hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25402?source=see_link\">",
"     \"Approach to the immunocompromised patient with fever and pulmonary infiltrates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13930?source=see_link\">",
"     \"Overview of neutropenic fever syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28552?source=see_link\">",
"     \"Diagnostic approach to the adult presenting with neutropenic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY OF POSTOPERATIVE FEVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever is a manifestation of cytokine release in response to a variety of stimuli [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Fever-associated cytokines, including interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma, are produced by a variety of tissues and cells (",
"    <a class=\"graphic graphic_algorithm graphicRef80455 \" href=\"UTD.htm?29/42/30382\">",
"     algorithm 1",
"    </a>",
"    ). There is some evidence that IL-6 is the cytokine most closely correlated with postoperative fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/11\">",
"     11",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/10/8361?source=see_link\">",
"     \"Pathophysiology and treatment of fever in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Fever-associated cytokines are released by tissue trauma and do not necessarily signal infection. The magnitude of the trauma is correlated with the degree of the fever response. For example, laparoscopic cholecystectomy is associated with less tissue trauma and fewer episodes of postoperative fever than is open cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/12\">",
"     12",
"    </a>",
"    ]. Similarly, there is less postoperative fever when coronary artery grafting is performed without the use of a cardiopulmonary bypass pump [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genetic factors may influence the magnitude of the cytokine release in response to tissue trauma, and thus the magnitude of self-limited postoperative fever. For example, children with osteogenesis imperfecta undergoing orthopedic surgery appear to have a greater and more sustained febrile response than matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacterial endotoxins and exotoxins can stimulate cytokine release and cause postoperative fever. Bacteria or fragments of bacteria translocated from the colon (eg, as a consequence of perioperative ileus or hypotension) may be responsible for some episodes of self-limited postoperative fever. Elevated levels of bacterial DNA have been demonstrated with polymerase chain reaction (PCR) testing of blood from surgical patients, even in patients whose blood cultures are negative [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Non-steroidal anti-inflammatory agents (NSAIDs) and glucocorticoids suppress cytokine release and thereby reduce the magnitude of the febrile response [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS BASED ON THE TIMING OF FEVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of fever after surgery is one of the most important factors to consider in generating a prioritized differential diagnosis of postoperative fever (",
"    <a class=\"graphic graphic_figure graphicRef51666 \" href=\"UTD.htm?32/16/33037\">",
"     figure 1",
"    </a>",
"    ). The timing of postoperative fever can be usefully described as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immediate &mdash; onset in the operating suite or within hours after surgery",
"     </li>",
"     <li>",
"      Acute &mdash; onset within the first week after surgery",
"     </li>",
"     <li>",
"      Subacute &mdash; onset from one to four weeks following surgery",
"     </li>",
"     <li>",
"      Delayed &mdash; onset more than one month after surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Immediate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential causes of fever in the immediate operative and postoperative period are mainly limited to: medications or blood products to which the patient was exposed during preoperative care either in the operating room or in the recovery area; trauma suffered prior to surgery or as part of surgery; infections that were present prior to surgery; and rarely malignant hyperthermia.",
"   </p>",
"   <p>",
"    Adverse medication reactions that produce immediate fever include immune-mediated reactions, such as reactions to antimicrobials and to transfused blood products. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/25/2456?source=see_link\">",
"     \"Drug fever\"",
"    </a>",
"    .) The vasodilation that often accompanies these reactions makes hypotension a common presenting sign; rash may accompany fever in some patients with medication reactions.",
"   </p>",
"   <p>",
"    The initial clinical signs (ie, hypercarbia) of malignant hyperthermia typically present within 30 minutes following the administration of a triggering agent (eg, inhaled anesthetics,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    ), but have been reported later in the operative course and also following cessation of anesthesia. If the malignant hyperthermia response is not recognized and aborted with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/22/22887?source=see_link\">",
"     dantrolene",
"    </a>",
"    , high fever may develop as result of hypermetabolism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32984?source=see_link\">",
"     \"Malignant hyperthermia: Clinical diagnosis and management of acute crisis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fever due to the trauma of surgery usually resolves within two to three days. The severity and duration of these self-limited postoperative fevers tend to be greater in patients with longer and more extensive surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/12\">",
"     12",
"    </a>",
"    ]. Fever caused by severe head trauma can be persistent and may resolve gradually over days or even weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are many causes of fever in the first week after surgery. Nosocomial infections are common during this period. Occasionally, fever or other symptoms predate surgery and are manifestations of community-acquired infection, such as a viral upper respiratory tract infection.",
"   </p>",
"   <p>",
"    While SSI and intravascular catheter infections can cause acute postoperative fever, other infections are more frequently identified, including pneumonia and urinary tract infection (UTI).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients receiving mechanical ventilation during surgery are at risk for ventilator-associated pneumonia (VAP). The risk of VAP increases with the duration of mechanical ventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/19\">",
"       19",
"      </a>",
"      ]. The risk of pneumonia tapers to a stable, lower rate over the first postoperative week and with the discontinuation of mechanical ventilation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=see_link\">",
"       \"Clinical presentation and diagnosis of ventilator-associated pneumonia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with depressed mental status or gag reflex due to anesthesia and analgesia are more susceptible to aspiration if they vomit after surgery. A nasogastric tube also increases gastroesophageal reflux and the risk for aspiration [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"       \"Aspiration pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      UTI is a frequent cause of postoperative fever in patients with indwelling urethral catheters. The risk of UTI increases with the duration of catheterization [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. UTI is more common in patients who have undergone a genitourinary procedure and in those who have chronic, indwelling catheters prior to surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=see_link\">",
"       \"Urinary tract infection associated with urethral catheters\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      SSI most often presents in the subacute period, one week or more after surgery. However, two organisms, group A streptococcus (GAS) and Clostridium perfringens, can cause fulminant SSI within a few hours after surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"       \"Necrotizing soft tissue infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/62/12264?source=see_link\">",
"       \"Clostridial myonecrosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Catheter exit site infections and bacteremia associated with intravascular catheters also tend to occur subacutely but should be considered as sources of fever in any patient with a catheter in place, especially if insertion was performed under emergent or nonsterile conditions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37464?source=see_link\">",
"       \"Epidemiology, pathogenesis, and microbiology of intravascular catheter infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute fever can also be caused by noninfectious conditions. Pancreatitis, myocardial infarction, pulmonary embolism, thrombophlebitis, alcohol withdrawal, and acute gout can complicate the acute postoperative period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Subacute",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSI is a common cause of fever more than one week after surgery; many patients have already been discharged from the hospital by this time [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36406?source=see_link\">",
"     \"Epidemiology and pathogenesis of and risk factors for surgical site infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21113?source=see_link\">",
"     \"Abdominal surgical incisions: Prevention and treatment of complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Central venous catheters, if used, can be a source of infection and fever. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37464?source=see_link\">",
"     \"Epidemiology, pathogenesis, and microbiology of intravascular catheter infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fever from antibiotic-associated diarrhea, typically attributed to Clostridium difficile, also occurs more commonly during this period. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=see_link\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Febrile drug reactions are a frequent cause of subacute fever. Beta-lactam antibiotics and sulfa-containing products are commonly implicated, but other medications, such as H2-blockers,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , should be considered.",
"   </p>",
"   <p>",
"    Thrombophlebitis should be considered as a cause of subacute fever in a patient with impaired mobility. Deep venous thrombosis and pulmonary embolism can cause fever and are more frequent in patients who are debilitated either by chronic medical problems or by the surgery.",
"   </p>",
"   <p>",
"    Patients who require critical care after surgery are at higher risk for the development of subacute fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/27\">",
"     27",
"    </a>",
"    ]. These patients typically develop a variety of postoperative complications. Nosocomial infections are more common in these patients because of their treatment with invasive medical devices. Device-related infections due to bacteria and fungi include intravascular catheter-related infection with or without bacteremia, VAP, UTI, and sinusitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/1/34840?source=see_link\">",
"     \"Infections and antimicrobial resistance in the intensive care unit\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Delayed",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most delayed postoperative fevers are due to infection, although fever due to postpericardiotomy syndrome should be considered in patients following cardiac surgery.",
"   </p>",
"   <p>",
"    Viral infections from blood products, including cytomegalovirus (CMV), hepatitis viruses, and human immunodeficiency virus (HIV), can arise late in postoperative patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/13\">",
"     13",
"    </a>",
"    ]. Parasitic infections (eg, toxoplasmosis, babesiosis, Plasmodium malariae infection) can also rarely be transmitted via transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/28-31\">",
"     28-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SSIs due to more indolent microorganisms (eg, coagulase-negative staphylococci) can cause delayed fever, especially in patients with implanted medical devices. These devices generally need to be removed in order to cure the infection. Patients can also develop delayed cellulitis when surgery has disrupted venous or lymphatic drainage; this type of cellulitis can be recurrent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24262?source=see_link\">",
"     \"Recurrent cellulitis after saphenous venectomy for coronary artery bypass graft surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14803?source=see_link\">",
"     \"Cellulitis following pelvic lymph node dissection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43991?source=see_link\">",
"     \"Breast cellulitis: Clinical manifestations, diagnosis, and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infective endocarditis due to perioperative bacteremia is also more likely to present weeks or months after surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CAUSES OF POSTOPERATIVE FEVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the list of causes of postoperative fever is extensive (",
"    <a class=\"graphic graphic_table graphicRef69959 \" href=\"UTD.htm?39/14/40172\">",
"     table 1",
"    </a>",
"    ), the initial focus for most patients should be on a limited number of the more common infectious and noninfectious causes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Infectious",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSI, pneumonia (especially VAP), UTI, and intravascular catheter-associated infection are the most common infectious causes of postoperative fever. Nosocomial bacterial and fungal pathogens are usually implicated. The infecting microorganisms generally are found as endogenous flora of the skin or bowel, but the flora change as patients are hospitalized for longer periods and receive antimicrobial therapy.",
"   </p>",
"   <p>",
"    When patients are readmitted to the hospital, organisms acquired in the community may also be involved. As an example, Pasteurella multocida SSIs have been caused by pet cats and dogs licking a surgical site [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Viral infections in the postoperative patient are usually associated with the transfusion of blood products. As an example, West Nile virus was recognized to be transmitted both by blood products [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/35\">",
"     35",
"    </a>",
"    ] and by organ donation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/36\">",
"     36",
"    </a>",
"    ]; nucleic acid amplification screening of donated blood has the potential to virtually eliminate this route of transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/37\">",
"     37",
"    </a>",
"    ]. The incubation period between blood product transfusion or organ transplantation and the onset of symptoms of West Nile virus infection ranged from 2 to 21 days. The median incubation period for blood product recipients was shorter than for transplantation recipients (10 and 13.5 days respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/38\">",
"     38",
"    </a>",
"    ]. Donated blood is screened by immunoassay techniques for a number of viruses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=see_link&amp;anchor=H8#H8\">",
"     \"Laboratory testing of donated blood\", section on 'Infectious disease screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Viral infections in the postoperative patient can also be transmitted nosocomially, as has occurred with SARS [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/39\">",
"     39",
"    </a>",
"    ]. Finally, postoperative viral infections, such as VAP can occasionally be caused by the reactivation of latent viruses, such as CMV or herpes simplex virus (HSV), especially in immunosuppressed patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/40-42\">",
"     40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other postoperative infections include [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/43\">",
"     43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sinusitis and, less commonly, otitis media, especially in patients with nasotracheal or nasogastric tubes. Mild sinusitis in a critically ill patient may not be clinically significant [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/44,45\">",
"       44,45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bacterial meningitis in patients after neurosurgical or head and neck procedures that inadvertently violated the subarachnoid space causing a \"CSF leak\".",
"     </li>",
"     <li>",
"      Parotitis, usually due to Staphylococcus aureus, in patients who have undergone manipulation of the oral cavity or are significantly dehydrated postoperatively. This postoperative infection is far less frequent with modern anesthesia and perioperative care [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acalculous cholecystitis can occur as a postoperative infection and recent surgery is second only to trauma as a cause of this complication [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Toxic shock syndrome is uncommon, but can occur, particularly in patients with nasal or vaginal packing that may facilitate the growth of S. aureus or GAS [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/48,49\">",
"       48,49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=see_link\">",
"       \"Staphylococcal toxic shock syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6616?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Noninfectious",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninfectious causes of postoperative fever include underlying conditions that are unmasked by the stress of surgery (",
"    <a class=\"graphic graphic_table graphicRef69959 \" href=\"UTD.htm?39/14/40172\">",
"     table 1",
"    </a>",
"    ). Other causes to be considered are:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications are the most common noninfectious cause of fever. Antimicrobials and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    are the medications most commonly associated with postoperative fever, at least in part because they are used so frequently in the postoperative period (",
"    <a class=\"graphic graphic_table graphicRef82602 \" href=\"UTD.htm?6/24/6540\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/25/2456?source=see_link\">",
"     \"Drug fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several medications commonly used in the postoperative period can interact with SSRIs or other antidepressants to precipitate fever as one manifestation of the serotonin syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link&amp;anchor=H399780619#H399780619\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\", section on 'Drug-drug interactions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additionally, antimicrobials and other medications incorporated into implanted materials may cause postoperative fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Malignant hyperthermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant hyperthermia is an inherited disorder most commonly manifesting as hypermetabolism during general anesthesia. MH-susceptible patients have genetic skeletal muscle receptor abnormalities allowing excessive calcium accumulation in the presence of certain anesthetic triggering agents. Prompt recognition of the initial clinical signs and treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/22/22887?source=see_link\">",
"     dantrolene",
"    </a>",
"    limits the morbidity and mortality associated with this disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36921?source=see_link\">",
"     \"Susceptibility to malignant hyperthermia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32984?source=see_link\">",
"     \"Malignant hyperthermia: Clinical diagnosis and management of acute crisis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical site inflammation without infection, including seroma and hematoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Gout",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gout and pseudogout in association with joint inflammation and effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Oncologic surgery or concomitant cancer may be additional risk factors for postoperative gout and joint manipulation and hyperparathyroidism for pseudogout. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gout\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7785?source=see_link\">",
"     \"Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatitis can result from surgery involving the upper abdomen [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/53\">",
"     53",
"    </a>",
"    ], an adverse reaction to perioperative medications, or preoperative alcoholism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14297?source=see_link\">",
"     \"Etiology of acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Deep venous thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep vein thrombosis (DVT) and pulmonary embolization are more common after procedures either directly or indirectly resulting in venous stasis, such as oncologic, pelvic, orthopedic, and neurosurgeries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link&amp;anchor=H25#H25\">",
"     \"Overview of the causes of venous thrombosis\", section on 'Surgery'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link&amp;anchor=H26#H26\">",
"     \"Overview of the causes of venous thrombosis\", section on 'Trauma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Fat embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fat embolism occurs most frequently after surgeries for major blunt trauma or major orthopedic surgery (particularly those involving long bone and pelvic fractures) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. It can also develop after liposuction [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/58\">",
"     58",
"    </a>",
"    ] and is part of the differential diagnosis in postoperative patients suffering from acute sickle cell chest syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25942?source=see_link\">",
"     \"Fat embolism syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Cardiovascular and stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial infarction, stroke, and subarachnoid hemorrhage can cause postoperative fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/60-62\">",
"     60-62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Transfusion reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusion reactions, such as delayed serologic and hemolytic transfusion reactions (DSTRs, DHTRs), are more common in patients previously sensitized to foreign antigens through prior transfusion or multiple pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=see_link\">",
"     \"Immunologic blood transfusion reactions\"",
"    </a>",
"    .) Complement activation due to antibody incompatibilities can also cause acute lung injury in the syndrome of Transfusion Related Acute Lung Injury (TRALI) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=see_link\">",
"     \"Transfusion-related acute lung injury (TRALI)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Endocrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperthyroidism or thyroid storm can occasionally cause postoperative fever. Although hyperthyroidism is more common in patients undergoing thyroid or other neck surgeries, it can also occur after other surgeries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. Acute adrenal insufficiency or Addisonian crisis has also been reported to occur after surgery, usually due to bilateral adrenal hemorrhagic infarction from coagulopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. The diagnosis can be obscure but is important because treatment with glucocorticoids can be lifesaving [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33800?source=see_link\">",
"     \"Clinical manifestations of adrenal insufficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Atelectasis (not causal)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atelectasis is often used as an explanation for otherwise unexplained postoperative fever. Both atelectasis and fever occur frequently after surgery, but their concurrence is probably coincidental rather than causal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/61/35795?source=see_link\">",
"     \"Atelectasis: Types and pathogenesis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 270 consecutive patients after abdominal surgery, the sensitivity and negative predictive value of fever as a predictor of atelectasis were both less than 50 percent, and the specificity and positive predictive value were 68 and 66 percent respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study, there was also no association between fever and the presence of, or the degree of, atelectasis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/73\">",
"       73",
"      </a>",
"      ]. Therefore, ascribing a postoperative fever to atelectasis is probably false reassurance and may mislead the clinician from pursuing the true cause of the fever.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Neuroleptic malignant syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroleptic malignant syndrome causing high fever and rigidity can develop perioperatively in patients receiving antipsychotic agents, especially",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/74\">",
"     74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/4/20553?source=see_link\">",
"     \"Neuroleptic malignant syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CONSIDERATIONS FOLLOWING SPECIFIC SURGERIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Cardiothoracic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever is common in the first few days after cardiothoracic surgery; additional investigation in febrile but otherwise clinically unremarkable postoperative patients is probably not indicated until the third postoperative day [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. Individual indicators of infection, including fever, are unreliable in the immediate postoperative period. Aggregate measures of physiologic instability such as a persistently poor APACHE score can identify patients more likely to have serious infectious complications [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/77\">",
"     77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/56/27527?source=see_link&amp;anchor=H5#H5\">",
"     \"Predictive scoring systems in the intensive care unit\", section on 'Acute Physiologic and Chronic Health Evaluation (APACHE)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pneumonia is a common cause of fever after cardiac surgery and may occur in more than five percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/78\">",
"     78",
"    </a>",
"    ]. Pneumonia is correlated with reintubation, hypotension, neurologic dysfunction, and transfusion of more than three units of blood components [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/78\">",
"     78",
"    </a>",
"    ]. Pleural effusions are the rule in patients following cardiac surgery; thoracentesis is rarely required during the evaluation of fever in such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Sternal wound infection and mediastinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sternal wound infection occurs in 1 to 5 percent of patients after median sternotomy. It is detected at a median of seven postoperative days; however, the range in one series was 3 to 417 days [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/79\">",
"     79",
"    </a>",
"    ]. Sternal wound infection more than one month after surgery is unusual (only nine percent in another study [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/80\">",
"     80",
"    </a>",
"    ]). Mediastinitis is associated with significant mortality (14 to 47 percent in contemporary series [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/79,81,82\">",
"     79,81,82",
"    </a>",
"    ]) and causes protracted hospitalization and an increased need for reoperation and rehospitalization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/48/1800?source=see_link\">",
"     \"Postoperative mediastinitis after cardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=see_link\">",
"     \"Surgical management of sternal wound complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A positive blood culture in a persistently febrile patient can be the first manifestation of a sternal wound infection, occurring before apparent wound inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/83\">",
"     83",
"    </a>",
"    ]. Risk factors for sternal wound infection include surgeries that are emergent, longer, more complex, or include internal mammary artery grafting; and patients who are older, diabetic, dialysis-dependent, obese, or smoke [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/25,84-87\">",
"     25,84-87",
"    </a>",
"    ]. Endocarditis should be considered in patients who develop positive blood cultures after undergoing valve replacement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/40/2697?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Culture of Staphylococcus aureus from the blood raises the possibility of mediastinitis, even if the wound appears uninfected [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/48/1800?source=see_link\">",
"     \"Postoperative mediastinitis after cardiac surgery\"",
"    </a>",
"    .) Recovery of organisms other than S. aureus from blood cultures, however, does not appear to be associated with mediastinitis. One study found that among patients who had undergone coronary artery bypass graft surgery and had blood cultures that grew an organism other than S. aureus, only 12 percent developed mediastinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/89\">",
"     89",
"    </a>",
"    ]. Coagulase-negative staphylococci are another common cause of sternal wound infections; sternal wound infections due to these organisms are often clinically less apparent than those due to S. aureus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/83,84,90\">",
"     83,84,90",
"    </a>",
"    ]. Sternal wound dehiscence without apparent infection is a clue for infection due to coagulase-negative staphylococci [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Candida species account for most postoperative fungal infections, but Aspergillus infections also occur [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/91\">",
"     91",
"    </a>",
"    ]. Aspergillus infections usually present months to years after surgery with persistent fever and negative blood cultures and a mortality rate greater than 80 percent. To minimize the risk of postoperative Aspergillus infection and its associated morbidity and mortality, it is critical to maintain hospital surveillance and to investigate and address any apparent outbreaks [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An important noninfectious cause of fever after cardiothoracic surgery is the postpericardiotomy syndrome, which can present days to weeks after surgery with fatigue and chest pain, with or without pericardial effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/60,93\">",
"     60,93",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20968?source=see_link\">",
"     \"Post-cardiac injury syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Neurosurgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningitis is a frequent and serious cause of fever after neurosurgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/94\">",
"     94",
"    </a>",
"    ]. Classic symptoms and signs of meningeal inflammation, such as headache, photophobia, and nuchal rigidity, are usually not helpful because they can be caused either by infection or by hemolyzed blood from the surgery irritating the meninges. Microscopic and analytical examination of the cerebrospinal fluid (CSF) is indicated in patients with fever, because, combined with specific clinical findings, characteristics of the CSF can help to distinguish patients with infections from those with chemical meningitis. Patients with all of the following criteria can probably be safely observed without administration of antimicrobials: fever less than 39.4&ordm;C (102.9&ordm;F); CSF WBC less than",
"    <span class=\"nowrap\">",
"     7,500/&micro;L;",
"    </span>",
"    CSF glucose above 10",
"    <span class=\"nowrap\">",
"     mg/dL;",
"    </span>",
"    no delirium, seizure, or surgical site inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurosurgical procedures that impact the hypothalamus can lead to disorders of thermoregulation and cause postoperative fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    DVT occurs more frequently after neurosurgery than after many other types of surgery. Not only is the patient likely to have limited mobility before and after surgery, but prophylactic anticoagulation is often less aggressive for neurosurgery because of concern for central nervous system hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Vascular surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Graft infections after vascular surgery may occur by direct inoculation of the surgical site or, less frequently, by hematogenous spread. Infection is more common in grafts at inguinal and upper leg surgical sites. Vascular graft infections most commonly present soon after surgery, but can occur months to years later.",
"   </p>",
"   <p>",
"    Determining that a graft is infected can be difficult. In addition to systemic symptoms such as fatigue, and anorexia, and signs such as fever, imaging with CT scanning, MRI, or scintigraphy can be helpful. Negative findings on imaging studies do not rule out a graft infection, but positive findings help to confirm infection and to guide aspiration for microbiologic analysis.",
"   </p>",
"   <p>",
"    In patients who undergo endovascular repair of aortic aneurysms with endoluminal stent-grafts, a syndrome has been described that can include fever, leukocytosis, elevated C-reactive protein levels, and perigraft gas seen radiographically. Fever above 101.4&ordm;F (38.6&ordm;C) has been reported in up to two-thirds of patients in some series. Blood cultures are negative, and the fevers resolve without antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25626?source=see_link&amp;anchor=H958077046#H958077046\">",
"     \"Complications of endovascular abdominal aortic repair\", section on 'Postimplantation syndrome'",
"    </a>",
"    .) This is sometimes referred to as \"postimplantation syndrome\"; its cause is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/99,100\">",
"     99,100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another noninfectious cause of fever after vascular surgery is arterial embolization, or \"blue toe\" syndrome. A similar syndrome can be caused by emboli from an infected graft. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=see_link\">",
"     \"Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Abdominal surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary cause of postoperative fever that is unique to abdominal surgery is deep abdominal abscess. Distinguishing between abscess, hematoma, and a benign peritoneal fluid collection can be difficult. Imaging studies and needle aspiration may be helpful, but exploration is sometimes necessary. Empiric antimicrobial treatment should be directed at the combination of aerobic Gram negative enteric bacilli and anaerobes.",
"   </p>",
"   <p>",
"    Splenoportal thrombosis may cause fever following splenectomy, and is recognized with increased frequency since the availability of CT scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/101\">",
"     101",
"    </a>",
"    ]. Risk factors include massive splenomegaly, and myeloproliferative and hemolytic disorders.",
"   </p>",
"   <p>",
"    Pancreatitis more frequently causes postoperative fever after upper abdominal surgeries than after other surgeries. Diagnosis can be made by elevated serum amylase and lipase concentrations with the considerations that salivary glands also produce amylase, and macro variants of amylase can produce elevated serum concentrations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Obstetric and gynecologic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum endometritis, manifested by fever, pelvic pain and purulent vaginal discharge, is more common in patients with preexisting medical problems, after premature rupture of membranes, difficult deliveries, and after the use of internal fetal monitoring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39097?source=see_link\">",
"     \"Postpartum endometritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of fever after gynecologic surgery includes urinary tract infection (UTI), cellulitis, necrotizing fasciitis, superficial abscess, deep abscess, and pelvic thrombophlebitis. As with other major surgeries, fever in the first day or two after gynecologic surgery usually resolves spontaneously. Extensive laboratory testing is not beneficial; fever evaluation should be targeted to the individual patient, based on repeated assessment of symptoms and signs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/102,103\">",
"     102,103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Deep abscess and pelvic thrombophlebitis are possible causes in patients with an unrevealing evaluation and persistent fever. Similar to abdominal surgery, identifying a fluid collection and distinguishing between abscess, hematoma, and a benign fluid collection, though difficult, can be critically important.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Urologic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection of the urinary tract at any level is the major consideration in evaluating patients with fever after urologic surgery. Although bacteriuria due to a urethral catheter is common, culture alone is not as revealing as the combination of urine culture findings and urine analysis for pyuria and bacteriuria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=see_link\">",
"     \"Urinary tract infection associated with urethral catheters\"",
"    </a>",
"    .) Deep infections, such as prostatic and perinephric abscess, may present with fever and pain, but relatively benign urine findings. Infection can also spread from the lower urinary tract through Batson's venous plexus to the lumbar spine and present after the UTI is resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Orthopedic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other major surgeries, self-limited fever is the rule after major orthopedic surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/6\">",
"     6",
"    </a>",
"    ]. The dominant special considerations in the differential diagnosis of persistent fever are surgical site infection (SSI), infected prosthesis, hematoma, and DVT. Repeat clinical assessment, imaging, and sometimes needle aspiration may be required to adequately assess the surgical site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluating fever after transplantation surgery requires special considerations due to immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. In addition to usual bacterial infections, medication reactions, and DVT, immunosuppression can enable reactivation of viral and protozoan infections from the patient or the donor [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/106\">",
"     106",
"    </a>",
"    ]. In addition, organ rejection and immunosuppression related lymphoma are both associated with delayed fever. Finally, immunosuppressive medications such as corticosteroids can mask fever.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     APPROACH TO THE PATIENT WITH FEVER AFTER SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiography, urinalysis, and blood and urine cultures are",
"    <strong>",
"     not",
"    </strong>",
"    indicated for all postoperative patients with fever. The need for laboratory testing should be determined by the findings of a careful history and physical examination. The febrile postoperative patient should be evaluated systematically (",
"    <a class=\"graphic graphic_table graphicRef79357 \" href=\"UTD.htm?18/48/19213\">",
"     table 3",
"    </a>",
"    ), taking into account the timing of the onset of fever and the many possible causes (",
"    <a class=\"graphic graphic_table graphicRef69959 \" href=\"UTD.htm?39/14/40172\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/7,102,107\">",
"     7,102,107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A useful initial screen for the more common causes of postoperative fever is represented by the four-part mnemonic \"Wind, Water, Wound, What did we do?\". \"Wind\" refers to pulmonary causes of fever including pneumonia, aspiration, and pulmonary embolism (but not atelectasis). \"Water\" refers to UTI, and \"Wound\" refers to SSI. \"What did we do?\" is a reminder to consider treatments as a cause of fever and includes medications, blood product transfusions, and intravascular, urethral, nasal, and abdominal catheters.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Procalcitonin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of serum procalcitonin (PCT) concentration for differentiating bacterial infection from other causes of postoperative fever has been explored in a few studies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/108,109\">",
"     108,109",
"    </a>",
"    ]. PCT is produced in C cells of the thyroid and is a more specific marker of bacterial infection than CRP. However, postoperative PCT concentrations vary substantially following different types of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/109\">",
"     109",
"    </a>",
"    ], and from patient to patient following the same type of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/110\">",
"     110",
"    </a>",
"    ]. Furthermore, PCT has not been found to be a reliable marker for infection in other settings (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35576?source=see_link\">",
"     \"Fever in the intensive care unit\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=see_link\">",
"     \"Evaluation and management of severe sepsis and septic shock in adults\"",
"    </a>",
"    ). We do not suggest the use of PCT in the evaluation of postoperative fever, pending additional clinical evidence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any unnecessary treatments, including medications and catheters, should be discontinued in patients with postoperative fever. It is probably appropriate to suppress the fever in most patients with one or two days of scheduled",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    to minimize patient discomfort and the physiologic stress and metabolic demands of fever and shivering [",
"    <a class=\"abstract\" href=\"UTD.htm?18/46/19178/abstract/111\">",
"     111",
"    </a>",
"    ]. This approach is unlikely to mask a significant pathologic condition. Additional treatment depends upon the cause of the fever.",
"   </p>",
"   <p>",
"    The decision to administer antibiotics to a patient with postoperative fever depends upon careful clinical assessment including an appraisal of the patient's stability. Patients who have undergone major surgery and are receiving intensive care and patients with hemodynamic instability generally should be treated empirically with broad-spectrum antibiotics after cultures have been obtained. For example, a patient with a suspected intraabdominal or pelvic infection should be treated with a regimen effective against aerobic Gram negative enteric bacilli and anaerobes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42617?source=see_link&amp;anchor=H8#H8\">",
"     \"Anaerobic bacterial infections\", section on 'Intraabdominal infections'",
"    </a>",
"    .) Empiric antifungal therapy should not be included unless the patient is at high risk for fungal infection.",
"   </p>",
"   <p>",
"    Nosocomial pathogens are often resistant to many antimicrobials; hospital antibiograms can be useful for selecting an appropriate broad-spectrum regimen. If a source of fever is not apparent and blood cultures show no growth after 48 hours, then discontinuation of antimicrobials should be seriously considered.",
"   </p>",
"   <p>",
"    If a site of infection is identified",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cultures are positive, the broad-spectrum regimen should be focused to cover the probable or known causative organism(s). Antimicrobial treatment beyond the empiric period of 48 hours should be reserved for patients in whom an infection has been identified. Gram stain findings and hospital antibiograms can be used to guide empiric antimicrobial selection, but definitive treatment should be based upon antimicrobial susceptibility results from cultured organisms. Carefully selecting antimicrobial treatment can help to avoid adverse medication reactions and can help to minimize the prevalence of resistant organisms in the hospital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postoperative fever (&gt;38&deg;C, 100.4&deg;F) is common in the first few days after surgery and usually resolves spontaneously. This febrile response may be due to tissue trauma with cytokine release, circulating bacterial endotoxins from endogenous gut flora, or other causes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology of postoperative fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In establishing a differential diagnosis for postoperative fever, it is helpful to take into account the timing of fever onset following surgery: immediate, acute, subacute, or delayed. The differential diagnosis of postoperative fever includes infectious and noninfectious etiologies. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Differential diagnosis based on the timing of fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical site infection, pneumonia, urinary tract infection, and intravascular catheter infection are the predominant infectious causes of postoperative fever, and are often due to nosocomial multi-drug-resistant organisms (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Infectious'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common noninfectious cause of postoperative fever is a medication reaction; antimicrobial agents or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      are the drugs most frequently implicated (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Medication'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Atelectasis and fever can both occur after surgery; however they do not correlate well with each other. Although atelectasis is often cited as a cause of postoperative fever, the association is probably coincidental and not causal. (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Atelectasis (not causal)'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Fever occurring in a patient who is otherwise doing well clinically within two days following cardiovascular surgery probably does not need further evaluation. A more delayed fever can be due to a variety of causes. Pneumonia occurs in more than 5 percent of sternotomy patients, and sternal complications in 1 to 5 percent. Mediastinitis is a serious complication and is usually due to Staphylococcus species. The postpericardiotomy fever syndrome may occur weeks after surgery. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Cardiothoracic surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Meningitis may be difficult to diagnose following neurosurgery, because neurosurgery can cause meningeal irritation without infection. Cerebrospinal fluid should be obtained for glucose concentration and microbiologic studies (gram stain and bacterial culture) to help determine the need for empiric antimicrobial therapy. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Neurosurgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vascular graft infections are more common after revascularization involving the groin or lower extremities. In patients undergoing endovascular aortic aneurysm repair, a postimplantation syndrome with fever but no infection is uncommon but has been described. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Vascular surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fever following abdominal surgery may be due to intraabdominal abscess and exploration may be necessary if needle aspiration and imaging studies are inconclusive. Pancreatitis more frequently complicates upper abdominal surgery than other surgeries. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Abdominal surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endometritis is more common following complicated deliveries. Fever soon after pelvic surgery is most often transient, but may be due to urinary tract infection, cellulitis, abscess, or pelvic thrombophlebitis. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Obstetric and gynecologic surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fever evaluation in the post-transplant patient is complicated by the increased likelihood of opportunistic infections due to concomitant immunosuppression. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Transplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest X-ray, urinalysis, and blood cultures are not indicated for most febrile postoperative patients. Evaluation should be tailored to the individual patient based on history, symptoms and physical findings. (See",
"      <a class=\"local\" href=\"#H33\">",
"       'Approach to the patient with fever after surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All unnecessary treatments, including medications, nasogastric tubes and intravascular and urinary catheters should be discontinued in the febrile patient. Treating the fever with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      is often appropriate. Antibiotics are not routinely indicated for most patients with fever in the early postoperative period, but hemodynamically unstable patients should be treated empirically with broad spectrum antibiotics, which should be discontinued after 48 hours if no source of infection has been identified. (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/1\">",
"      Garibaldi RA, Brodine S, Matsumiya S, Coleman M. Evidence for the non-infectious etiology of early postoperative fever. Infect Control 1985; 6:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/2\">",
"      Galicier C, Richet H. A prospective study of postoperative fever in a general surgery department. Infect Control 1985; 6:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/3\">",
"      Livelli FD Jr, Johnson RA, McEnany MT, et al. Unexplained in-hospital fever following cardiac surgery. Natural history, relationship to postpericardiotomy syndrome, and a prospective study of therapy with indomethacin versus placebo. Circulation 1978; 57:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/4\">",
"      Hobar PC, Masson JA, Herrera R, et al. Fever after craniofacial surgery in the infant under 24 months of age. Plast Reconstr Surg 1998; 102:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/5\">",
"      Guinn S, Castro FP Jr, Garcia R, Barrack RL. Fever following total knee arthroplasty. Am J Knee Surg 1999; 12:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/6\">",
"      Ghosh S, Charity RM, Haidar SG, Singh BK. Pyrexia following total knee replacement. Knee 2006; 13:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/7\">",
"      Kiragu AW, Zier J, Cornfield DN. Utility of blood cultures in postoperative pediatric intensive care unit patients. Pediatr Crit Care Med 2009; 10:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/8\">",
"      Netea MG, Kullberg BJ, Van der Meer JW. Circulating cytokines as mediators of fever. Clin Infect Dis 2000; 31 Suppl 5:S178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/9\">",
"      Blatteis CM, Sehic E, Li S. Pyrogen sensing and signaling: old views and new concepts. Clin Infect Dis 2000; 31 Suppl 5:S168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/10\">",
"      Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med 1994; 330:1880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/11\">",
"      Mitchell, JD, Grocott, HP, Phillips-Bute, B, et al. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine 2007; 39:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/12\">",
"      Dauleh MI, Rahman S, Townell NH. Open versus laparoscopic cholecystectomy: a comparison of postoperative temperature. J R Coll Surg Edinb 1995; 40:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/13\">",
"      Clark JA, Bar-Yosef S, Anderson A, et al. Postoperative hyperthermia following off-pump versus on-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2005; 19:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/14\">",
"      Ghert M, Allen B, Davids J, et al. Increased postoperative febrile response in children with osteogenesis imperfecta. J Pediatr Orthop 2003; 23:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/15\">",
"      Kane TD, Alexander JW, Johannigman JA. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann Surg 1998; 227:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/16\">",
"      Held BI, Michels A, Blanco J, Ascher-Walsh C. The effect of ketorolac on postoperative febrile episodes in patients after abdominal myomectomy. Am J Obstet Gynecol 2002; 187:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/17\">",
"      Bisgaard T, Klarskov B, Kehlet H, Rosenberg J. Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg 2003; 238:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/18\">",
"      Sazbon L, Groswasser Z. Outcome in 134 patients with prolonged posttraumatic unawareness. Part 1: Parameters determining late recovery of consciousness. J Neurosurg 1990; 72:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/19\">",
"      Horan TC, Culver DH, Gaynes RP, et al. Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 1993; 14:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/20\">",
"      Manning BJ, Winter DC, McGreal G, et al. Nasogastric intubation causes gastroesophageal reflux in patients undergoing elective laparotomy. Surgery 2001; 130:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/21\">",
"      Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 1974; 291:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/22\">",
"      Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am 1999; 26:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/23\">",
"      Friedman C, Sturm LK, Chenoweth C. Electronic chart review as an aid to postdischarge surgical site surveillance: increased case finding. Am J Infect Control 2001; 29:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/24\">",
"      Sands K, Vineyard G, Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis 1996; 173:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/25\">",
"      Ridderstolpe L, Gill H, Granfeldt H, et al. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg 2001; 20:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/26\">",
"      Delgado-Rodr&iacute;guez M, G&oacute;mez-Ortega A, Sillero-Arenas M, Llorca J. Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study. Infect Control Hosp Epidemiol 2001; 22:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/27\">",
"      O'Grady NP, Barie PS, Bartlett JG, et al. Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis 1998; 26:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/28\">",
"      Chadee DD, Tilluckdharry CC, Maharaj P, Sinanan C. Reactivation of Plasmodium malariae infection in a Trinidadian man after neurosurgery. N Engl J Med 2000; 342:1924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/29\">",
"      Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344:1973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/30\">",
"      Dodd RY. Transmission of parasites by blood transfusion. Vox Sang 1998; 74 Suppl 2:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/31\">",
"      McQuiston JH, Childs JE, Chamberland ME, Tabor E. Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000; 40:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/32\">",
"      Baddour LM, Bisno AL. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med 1982; 97:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/33\">",
"      Baddour LM. Breast cellulitis complicating breast conservation therapy. J Intern Med 1999; 245:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/34\">",
"      Octavio J, Rosenberg W, Conte JE Jr. Surgical-wound infection with Pasteurella multocida from pet dogs. N Engl J Med 2001; 345:549.",
"     </a>",
"    </li>",
"    <li>",
"     Public health dispatch: Investigations of West Nile virus infections in recipients of blood transfusions. MMWR 2002; 51:973. Available at: file://www.cdc.gov/mmwr/preview/mmwrhtml/mm5143a5.htm (Accessed 9/9/05).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/36\">",
"      Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/37\">",
"      Stramer SL, Fang CT, Foster GA, et al. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/38\">",
"      Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/39\">",
"      Tan FL, Loo WL, Tan SG, et al. Severe acute respiratory syndrome in surgical patients: a diagnostic dilemma. ANZ J Surg 2005; 75:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/40\">",
"      Papazian L, Fraisse A, Garbe L, et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/41\">",
"      Camazine B, Antkowiak JG, Nava ME, et al. Herpes simplex viral pneumonia in the postthoracotomy patient. Chest 1995; 108:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/42\">",
"      Avery RK, Longworth DL. Viral pulmonary infections in thoracic and cardiovascular surgery. Semin Thorac Cardiovasc Surg 1995; 7:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/43\">",
"      Wallace WC, Cinat ME, Nastanski F, et al. New epidemiology for postoperative nosocomial infections. Am Surg 2000; 66:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/44\">",
"      Caplan ES, Hoyt NJ. Nosocomial sinusitis. JAMA 1982; 247:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/45\">",
"      Borman KR, Brown PM, Mezera KK, Jhaveri H. Occult fever in surgical intensive care unit patients is seldom caused by sinusitis. Am J Surg 1992; 164:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/46\">",
"      Raad II, Sabbagh MF, Caranasos GJ. Acute bacterial sialadenitis: a study of 29 cases and review. Rev Infect Dis 1990; 12:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/47\">",
"      Huffman JL, Schenker S. Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol 2010; 8:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/48\">",
"      Morrison VA, Oldfield EC 3rd. Postoperative toxic shock syndrome. Arch Surg 1983; 118:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/49\">",
"      Odom SR, Stallard JD, Pacheco HO, Ho H. Postoperative staphylococcal toxic shock syndrome due to pre-existing staphylococcal infection: case report and review of the literature. Am Surg 2001; 67:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/50\">",
"      Cobb WS, Paton BL, Novitsky YW, et al. Intra-abdominal placement of antimicrobial-impregnated mesh is associated with noninfectious fever. Am Surg 2006; 72:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/51\">",
"      Craig MH, Poole GV, Hauser CJ. Postsurgical gout. Am Surg 1995; 61:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/52\">",
"      Masuda I, Ishikawa K. Clinical features of pseudogout attack. A survey of 50 cases. Clin Orthop Relat Res 1988; :173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/53\">",
"      Hughes SG, Chekan EG, Ali A, et al. Unusual complications following laparoscopic Nissen fundoplication. Surg Laparosc Endosc Percutan Tech 1999; 9:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/54\">",
"      Pape HC, Giannoudis P, Krettek C. The timing of fracture treatment in polytrauma patients: relevance of damage control orthopedic surgery. Am J Surg 2002; 183:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/55\">",
"      Pell AC, Christie J, Keating JF, Sutherland GR. The detection of fat embolism by transoesophageal echocardiography during reamed intramedullary nailing. A study of 24 patients with femoral and tibial fractures. J Bone Joint Surg Br 1993; 75:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/56\">",
"      Pitto RP, Hamer H, Fabiani R, et al. Prophylaxis against fat and bone-marrow embolism during total hip arthroplasty reduces the incidence of postoperative deep-vein thrombosis: a controlled, randomized clinical trial. J Bone Joint Surg Am 2002; 84-A:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/57\">",
"      Jenkins K, Chung F, Wennberg R, et al. Fat embolism syndrome and elective knee arthroplasty. Can J Anaesth 2002; 49:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/58\">",
"      Platt MS, Kohler LJ, Ruiz R, et al. Deaths associated with liposuction: case reports and review of the literature. J Forensic Sci 2002; 47:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/59\">",
"      Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342:1855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/60\">",
"      Prince SE, Cunha BA. Postpericardiotomy syndrome. Heart Lung 1997; 26:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/61\">",
"      Koennecke HC, Leistner S. Prophylactic antipyretic treatment with acetaminophen in acute ischemic stroke: a pilot study. Neurology 2001; 57:2301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/62\">",
"      Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001; 56:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/63\">",
"      Ness PM, Shirey RS, Weinstein MH, King KE. An animal model for delayed hemolytic transfusion reactions. Transfus Med Rev 2001; 15:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/64\">",
"      Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/65\">",
"      So PC. Unmasking of thyrotoxicosis during anaesthesia. Hong Kong Med J 2001; 7:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/66\">",
"      Lee KS, Kim K, Hur KB, Kim CK. The role of propranolol in the preoperative preparation of patients with Graves' disease. Surg Gynecol Obstet 1986; 162:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/67\">",
"      Lynch BA, Dolan JP, Mann M. Thyrotoxicosis after gastric bypass surgery prompting operative re-exploration. Obes Surg 2005; 15:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/68\">",
"      Siu SC, Kitzman DW, Sheedy PF 2nd, Northcutt RC. Adrenal insufficiency from bilateral adrenal hemorrhage. Mayo Clin Proc 1990; 65:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/69\">",
"      Rao RH, Vagnucci AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med 1989; 110:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/70\">",
"      Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc 2001; 76:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/71\">",
"      Udelsman R, Ramp J, Gallucci WT, et al. Adaptation during surgical stress. A reevaluation of the role of glucocorticoids. J Clin Invest 1986; 77:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/72\">",
"      Roberts J, Barnes W, Pennock M, Browne G. Diagnostic accuracy of fever as a measure of postoperative pulmonary complications. Heart Lung 1988; 17:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/73\">",
"      Engoren M. Lack of association between atelectasis and fever. Chest 1995; 107:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/74\">",
"      Brown FE, Nierenberg DW, Nordgren RE, et al. Neuroleptic malignant syndrome: occurrence in a child after reconstructive surgery. Plast Reconstr Surg 1991; 87:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/75\">",
"      Pien F, Ho PW, Fergusson DJ. Fever and infection after cardiac operation. Ann Thorac Surg 1982; 33:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/76\">",
"      Wilson AP, Treasure T, Gr&uuml;neberg RN, et al. Should the temperature chart influence management in cardiac operations? Result of a prospective study in 314 patients. J Thorac Cardiovasc Surg 1988; 96:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/77\">",
"      Kreuzer E, K&auml;&auml;b S, Pilz G, Werdan K. Early prediction of septic complications after cardiac surgery by APACHE II score. Eur J Cardiothorac Surg 1992; 6:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/78\">",
"      Leal-Noval SR, Rinc&oacute;n-Ferrari MD, Garc&iacute;a-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001; 119:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/79\">",
"      Fari&ntilde;as MC, Gald Peralta F, Bernal JM, et al. Suppurative mediastinitis after open-heart surgery: a case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 1995; 20:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/80\">",
"      Bor DH, Rose RM, Modlin JF, et al. Mediastinitis after cardiovascular surgery. Rev Infect Dis 1983; 5:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/81\">",
"      El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/82\">",
"      Milano CA, Kesler K, Archibald N, et al. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation 1995; 92:2245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/83\">",
"      Kohman LJ, Coleman MJ, Parker FB Jr. Bacteremia and sternal infection after coronary artery bypass grafting. Ann Thorac Surg 1990; 49:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/84\">",
"      Mossad SB, Serkey JM, Longworth DL, et al. Coagulase-negative staphylococcal sternal wound infections after open heart operations. Ann Thorac Surg 1997; 63:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/85\">",
"      Mu&ntilde;oz P, Menasalvas A, Bernaldo de Quir&oacute;s JC, et al. Postsurgical mediastinitis: a case-control study. Clin Infect Dis 1997; 25:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/86\">",
"      Liu JY, Birkmeyer NJ, Sanders JH, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 2000; 102:2973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/87\">",
"      Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery--an updated risk factor analysis in 10,373 consecutive adult patients. Thorac Cardiovasc Surg 2002; 50:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/88\">",
"      Gottlieb GS, Fowler VG Jr, Kong LK, et al. Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. J Am Coll Surg 2000; 190:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/89\">",
"      Fowler VG Jr, Kaye KS, Simel DL, et al. Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation 2003; 108:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/90\">",
"      Tammelin A, Hambraeus A, St&aring;hle E. Mediastinitis after cardiac surgery: improvement of bacteriological diagnosis by use of multiple tissue samples and strain typing. J Clin Microbiol 2002; 40:2936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/91\">",
"      Weber SF, Washburn RG. Invasive Aspergillus infections complicating coronary artery bypass grafting. South Med J 1990; 83:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/92\">",
"      Isenberg HD, Tucci V, Cintron F, et al. Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989; 27:2426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/93\">",
"      Webber SA, Wilson NJ, Junker AK, et al. Postpericardiotomy syndrome: no evidence for a viral etiology. Cardiol Young 2001; 11:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/94\">",
"      Kaufman BA, Tunkel AR, Pryor JC, Dacey RG Jr. Meningitis in the neurosurgical patient. Infect Dis Clin North Am 1990; 4:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/95\">",
"      Forgacs P, Geyer CA, Freidberg SR. Characterization of chemical meningitis after neurological surgery. Clin Infect Dis 2001; 32:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/96\">",
"      Chatzisotiriou AS, Selviaridis PK, Kontopoulos VA, et al. Delayed persistent hyperthermia after resection of a craniopharyngioma. Pediatr Neurosurg 2004; 40:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/97\">",
"      Blum U, Voshage G, Lammer J, et al. Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N Engl J Med 1997; 336:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/98\">",
"      Vel&aacute;zquez OC, Carpenter JP, Baum RA, et al. Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms. Am J Surg 1999; 178:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/99\">",
"      Storck M, Scharrer-Pamler R, Kapfer X, et al. Does a postimplantation syndrome following endovascular treatment of aortic aneurysms exist? Vasc Surg 2001; 35:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/100\">",
"      B&ouml;lke E, Jehle PM, Storck M, et al. Endovascular stent-graft placement versus conventional open surgery in infrarenal aortic aneurysm: a prospective study on acute phase response and clinical outcome. Clin Chim Acta 2001; 314:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/101\">",
"      Romano F, Caprotti R, Conti M, et al. Thrombosis of the splenoportal axis after splenectomy. Langenbecks Arch Surg 2006; 391:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/102\">",
"      Schwandt A, Andrews SJ, Fanning J. Prospective analysis of a fever evaluation algorithm after major gynecologic surgery. Am J Obstet Gynecol 2001; 184:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/103\">",
"      Schey D, Salom EM, Papadia A, Penalver M. Extensive fever workup produces low yield in determining infectious etiology. Am J Obstet Gynecol 2005; 192:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/104\">",
"      Tanabe K, Takahashi K, Tokumoto T, et al. Infectious complications in ABO-incompatible living donor kidney transplantation: a single center experience. Transplant Proc 1998; 30:3130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/105\">",
"      Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338:1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/106\">",
"      Yoshikawa T, Ihira M, Furukawa H, et al. Four cases of human herpesvirus 6 variant B infection after pediatric liver transplantation. Transplantation 1998; 65:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/107\">",
"      Badillo AT, Sarani B, Evans SR. Optimizing the use of blood cultures in the febrile postoperative patient. J Am Coll Surg 2002; 194:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/108\">",
"      Clec'h C, Fosse JP, Karoubi P, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006; 34:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/109\">",
"      Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/110\">",
"      Michalik DE, Duncan BW, Mee RB, et al. Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery. Cardiol Young 2006; 16:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/46/19178/abstract/111\">",
"      Plaisance KI, Mackowiak PA. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med 2000; 160:449.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2886 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-652B83C886-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19178=[""].join("\n");
var outline_f18_46_19178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY OF POSTOPERATIVE FEVER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIFFERENTIAL DIAGNOSIS BASED ON THE TIMING OF FEVER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Immediate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Subacute",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Delayed",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CAUSES OF POSTOPERATIVE FEVER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Infectious",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Noninfectious",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Medication",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Malignant hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Gout",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Deep venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Fat embolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Cardiovascular and stroke",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Transfusion reaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Endocrine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Atelectasis (not causal)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Neuroleptic malignant syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CONSIDERATIONS FOLLOWING SPECIFIC SURGERIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Cardiothoracic surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Sternal wound infection and mediastinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Neurosurgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Vascular surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Abdominal surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Obstetric and gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Urologic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Orthopedic surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      APPROACH TO THE PATIENT WITH FEVER AFTER SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Procalcitonin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/2886\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2886|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?29/42/30382\" title=\"algorithm 1\">",
"      Pathways of fever production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2886|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/16/33037\" title=\"figure 1\">",
"      Timing of onset of postoperative infection and fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2886|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/14/40172\" title=\"table 1\">",
"      Causes of postoperative fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/24/6540\" title=\"table 2\">",
"      Medications associated with fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/48/19213\" title=\"table 3\">",
"      Evaluation of the patient with postoperative fever",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21113?source=related_link\">",
"      Abdominal surgical incisions: Prevention and treatment of complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/39/42617?source=related_link\">",
"      Anaerobic bacterial infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25402?source=related_link\">",
"      Approach to the immunocompromised patient with fever and pulmonary infiltrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/61/35795?source=related_link\">",
"      Atelectasis: Types and pathogenesis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43991?source=related_link\">",
"      Breast cellulitis: Clinical manifestations, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14803?source=related_link\">",
"      Cellulitis following pelvic lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=related_link\">",
"      Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=related_link\">",
"      Clinical manifestations and diagnosis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7785?source=related_link\">",
"      Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=related_link\">",
"      Clinical manifestations and diagnosis of gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33800?source=related_link\">",
"      Clinical manifestations of adrenal insufficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=related_link\">",
"      Clinical presentation and diagnosis of ventilator-associated pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/62/12264?source=related_link\">",
"      Clostridial myonecrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=related_link\">",
"      Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25626?source=related_link\">",
"      Complications of endovascular abdominal aortic repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/56/28552?source=related_link\">",
"      Diagnostic approach to the adult presenting with neutropenic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/25/2456?source=related_link\">",
"      Drug fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36406?source=related_link\">",
"      Epidemiology and pathogenesis of and risk factors for surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/40/2697?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6616?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37464?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of intravascular catheter infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14297?source=related_link\">",
"      Etiology of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/51/21306?source=related_link\">",
"      Evaluation and management of severe sepsis and septic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25942?source=related_link\">",
"      Fat embolism syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35576?source=related_link\">",
"      Fever in the intensive care unit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11769?source=related_link\">",
"      Immunologic blood transfusion reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/1/34840?source=related_link\">",
"      Infections and antimicrobial resistance in the intensive care unit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42537?source=related_link\">",
"      Infectious causes of fever and rash in non-HIV immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=related_link\">",
"      Laboratory testing of donated blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32984?source=related_link\">",
"      Malignant hyperthermia: Clinical diagnosis and management of acute crisis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=related_link\">",
"      Necrotizing soft tissue infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/4/20553?source=related_link\">",
"      Neuroleptic malignant syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13930?source=related_link\">",
"      Overview of neutropenic fever syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/10/8361?source=related_link\">",
"      Pathophysiology and treatment of fever in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20968?source=related_link\">",
"      Post-cardiac injury syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/48/1800?source=related_link\">",
"      Postoperative mediastinitis after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39097?source=related_link\">",
"      Postpartum endometritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/56/27527?source=related_link\">",
"      Predictive scoring systems in the intensive care unit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/44/24262?source=related_link\">",
"      Recurrent cellulitis after saphenous venectomy for coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=related_link\">",
"      Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/32/14858?source=related_link\">",
"      Surgical management of sternal wound complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/3/36921?source=related_link\">",
"      Susceptibility to malignant hyperthermia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/39/28282?source=related_link\">",
"      Transfusion-related acute lung injury (TRALI)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=related_link\">",
"      Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_46_19179="Criteria schizotype personality";
var content_f18_46_19179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for schizotypal personality disorder",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Five or more of following plus general criteria for personality disorder:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1. Ideas of reference",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Odd beliefs or magical thinking, that influence behavior and are inconsistent with subcultural norms",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3. Unusual perceptual experiences, including bodily illusions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4. Odd thinking and speech",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5. Suspiciousness or paranoid ideation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6. Inappropriate or constricted affect",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       7. Behavior or appearance that is odd, eccentric, or peculiar",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       8. Lack of close friends or confidants other than first-degree relatives",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       9. Excessive social anxiety that does not diminish with familiarity and tends to be associated with paranoid fears rather than negative judgments about self",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text revision (DSM-IV-TR). American Psychiatric Association, Washington, DC, 2000.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19179=[""].join("\n");
var outline_f18_46_19179=null;
var title_f18_46_19180="Common street names cocaine PI";
var content_f18_46_19180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common street names for cocaine",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Cocaine base (smokable)",
"       </td>",
"       <td>",
"        Base, black rock, crack, electric kool-aid, rock, gravel, purple caps, Scotty, scramble, supercoke, twinkie, window pane, yam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine HCl",
"       </td>",
"       <td>",
"        Aspirin, Big C, blow, coconut, coke, devil's dandruff, flake, Florida snow, foo-foo dust, happy dust, lady, nose candy, white dragon, white lady, yao",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine paste",
"       </td>",
"       <td>",
"        Basuco, bazooka, pasta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine in vagina",
"       </td>",
"       <td>",
"        Balling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + heroin",
"       </td>",
"       <td>",
"        Belushi, bipping, blanco, boy-girl, dynamite, goof ball, he-she, murder one, sandwich, snowball, speedball",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + marijuana",
"       </td>",
"       <td>",
"        51, banano, bazooka, blunt, C &amp; M, candy sticks, caviar, champagne, cocktail, cocoa puff, crack bash, dirties, geek-joint, Greek, lace, P-dogs, premos, primo, Sherman stick, woo blunts, woolie",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + MDMA (ecstasy)",
"       </td>",
"       <td>",
"        Bumping up",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + MDMA + LSD",
"       </td>",
"       <td>",
"        Candy flipping on a string",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + methamphetamine",
"       </td>",
"       <td>",
"        Croak, shabu",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + methcathinone",
"       </td>",
"       <td>",
"        Wild cat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + morphine",
"       </td>",
"       <td>",
"        C &amp; M",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + PCP",
"       </td>",
"       <td>",
"        Beam me up Scottie, space ball, space base, space dust",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + tobacco",
"       </td>",
"       <td>",
"        Cigamos, coolie, geek-joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + marijuana + PCP",
"       </td>",
"       <td>",
"        Jim Jones, speed boat, squirrel, wickie",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + heroin + tobacco",
"       </td>",
"       <td>",
"        Flamethrowers, primos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine + heroin + methamphetamine + flunitrazepam + alcohol",
"       </td>",
"       <td>",
"        Five-way",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note that street names change over time and may differ by location. The same name might refer to more than one drug.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19180=[""].join("\n");
var outline_f18_46_19180=null;
var title_f18_46_19181="Weight-based dosing of anesthetic medications in severe obesity";
var content_f18_46_19181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F63370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F63370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Weight-based dosing of anesthetic, analgesic, and adjunctive medications in severe obesity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Weight for calculating dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Notes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Induction agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Propofol",
"       </td>",
"       <td class=\"centered\">",
"        <p>",
"         LBW (induction/bolus dose)",
"        </p>",
"        Scale maintenance dose to TBW",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Etomidate",
"       </td>",
"       <td class=\"centered\">",
"        LBW",
"       </td>",
"       <td>",
"        Data evaluating etomidate dosing in obesity is scant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thiopental*",
"       </td>",
"       <td class=\"centered\">",
"        LBW",
"       </td>",
"       <td>",
"        Duration of effect may be prolonged in obese patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Opioids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fentanyl",
"       </td>",
"       <td class=\"centered\">",
"        IBW or LBW",
"       </td>",
"       <td>",
"        Dose needs to be reduced for prolonged infusion due to drug accumulation in non-lean tissues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Remifentanil",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sufentanil",
"       </td>",
"       <td class=\"centered\">",
"        TBW or LBW",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hydromorphone",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"       <td rowspan=\"2\">",
"        Duration of effect prolonged in obese patients after repeated dosing or use of continuous infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Morphine sulfate",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Benzodiazepines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lorazepam",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"       <td>",
"        Duration of effect prolonged in obese patients after repeated dosing or continuous infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Midazolam",
"       </td>",
"       <td class=\"centered\">",
"        LBW",
"       </td>",
"       <td>",
"        Duration of effect prolonged in obese patients after repeated dosing or continuous infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Neuromuscular blocking agents (non-depolarizing)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Atracurium",
"       </td>",
"       <td class=\"centered\">",
"        TBW or LBW",
"       </td>",
"       <td>",
"        Use of TBW for dosing of obese patients provides similar onset but prolonged duration of action compared with non-obese patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cisatracurium",
"       </td>",
"       <td class=\"centered\">",
"        IBW or LBW",
"       </td>",
"       <td>",
"        Use of IBW for dosing of obese patients can modestly increase time to onset and decrease duration of effect compared with non-obese patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mivacurium*",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"       <td>",
"        Obese patients may experience prolonged neuromuscular blockade by scaling dose to TBW and may experience transient hypotension on induction of anesthesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rocuronium",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"       <td>",
"        Use of IBW for dosing obese patients provides normal onset of effect. Higher doses will provide a faster onset but may result in significantly prolonged duration of effect.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vecuronium",
"       </td>",
"       <td class=\"centered\">",
"        IBW",
"       </td>",
"       <td>",
"        Use of IBW for dosing obese patients provides normal duration of effect. However, time to onset may be slightly prolonged.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Neuromuscular blocking agents (depolarizing)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Succinylcholine",
"       </td>",
"       <td class=\"centered\">",
"        TBW",
"       </td>",
"       <td>",
"        Best intubating conditions are most likely with this induction dose in morbidly obese patients",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Doses must be&nbsp;adjusted according to patient condition and clinical criteria including peripheral nerve&nbsp;monitoring for neuromuscular blocking agents.",
"    <div class=\"footnotes\">",
"     TBW: total (or actual) body weight; IBW: ideal body weight (also known as standard adult dose); LBW: lean body weight.",
"     <br>",
"      * Not available in US.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19181=[""].join("\n");
var outline_f18_46_19181=null;
var title_f18_46_19182="Prevalence of HTN in women";
var content_f18_46_19182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Prevalence of hypertension in women in the United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 251px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prevalence of hypertension in women according to age and race/ethnicity in the United States from the NHANES-III survey. Hypertension occurs earlier and more frequently in African-American women.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Burt VL, Whelton P, Roccella EJ, et al. Hypertension 1995; 25:305.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19182=[""].join("\n");
var outline_f18_46_19182=null;
var title_f18_46_19183="Anti-Ro52 staining";
var content_f18_46_19183=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F86982&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F86982&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Staining pattern produced by anti-Ro52 antibodies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 349px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Human serum containing antibodies directed against Ro52 stained the cytoplasm of HEp-2 cells. To demonstrate the cytoplasmic staining pattern produced by these antibodies, a plasmid encoding Ro52 fused to green fluorescent protein (GFP) was expressed in HEp-2 cells and was stained with mouse anti-GFP (green, panel A). Two of the five cells in the field were successfully transfected with the plasmid (indicated by white arrows). Human anti-Ro52 antibodies stained the cytoplasm of all the HEp-2 cells in the field, but staining was especially intense in cells over-expressing Ro52-GFP (red, panel B). DAPI staining (blue) in panel C indicates the location of nuclei.",
"    <div class=\"footnotes\">",
"     DAPI: 4',6'-diamidino-2-phenylindole.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Donald B Bloch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_46_19183=[""].join("\n");
var outline_f18_46_19183=null;
